医薬品受託販売市場レポート：2022-2032

Pharma Contract Sales Market Report 2022-2032

レポート詳細医薬品受託販売市場レポート 2022-2032 :有力企業が新たな収入源を求め、市場とその背景にある力学を理解したいと考えるなら、本レポートは貴重なものとなるでしょう。新市場への多角化... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
Visiongain ヴィジョンゲイン社	2022年10月31日	GBP4,500 部署ライセンスライセンス・価格情報・注文方法はこちら	365	376	英語

※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

レポート詳細

医薬品受託販売市場レポート 2022-2032:有力企業が新たな収入源を求め、市場とその背景にある力学を理解したいと考えるなら、本レポートは貴重なものとなるでしょう。新市場への多角化、あるいは現在の事業範囲の拡大を目指す企業にも役立つはずです。

製薬会社の研究開発の活発化がアウトソーシングのダイナミクスに変化をもたらす
中堅・大手製薬企業の多くは、製薬業界におけるR＆Dやその他の運営コストの上昇に対応するため、コスト管理、業績向上、業務の柔軟性などの観点から、業務のアウトソーシングを進めています。CSOは、市場アクセス、保健当局、ローカルアカウントマネジメントなどの経験を有しているため、近年CSOの数が増加しており、今後も増加すると予想されます。欧州のCSOは医薬品関係者の約3分の1を占めています。しかし、同じ地域で活動する多様な企業に対して、紛争になりかねない営業・マーケティングサービスを提供するCSOはほとんどないです。

医薬品の販売・サービスにおける品質放棄
製造委託先としては、できるだけ多くの製薬会社からの受注を確保することだけが課題である。そのため、1日1台でも多くコンピュータから注文を受けられるように努力する。何事もポテンシャルを発揮すると、どうしても品質が悪くなるはずだ。その不安は、きちんとした製造委託先と付き合うことで解消されます。医薬品の品質は、原料、製造方法、包装、輸送、保管など、さまざまな要因が複合的に影響します。

マーケットリサーチレポートを購入する前に、どのような質問をすべきでしょうか？
- 医薬品受託販売市場はどのように進化しているのか？
- 医薬品受託販売市場の推進要因と抑制要因は何か？
- 各医薬品受託販売サブマーケットセグメントは予測期間中にどのように成長し、これらのサブマーケットが2032年にどれだけの収益を占めるのか？
- 2022年から2032年にかけて、各医薬品受託販売サブマーケットの市場シェアはどのように推移するのか？
- 2022年から2032年にかけて、市場全体の主な牽引役となるのは何でしょうか？
- 医薬品受託販売の主要市場はマクロ経済のダイナミクスに概ね追随するのか、それとも個々の国内市場が他を凌駕するのか？
- 2032年までに各国市場のシェアはどのように変化し、どの地域が2032年の市場をリードするのでしょうか？
- 主要プレイヤーは誰か、また予測期間中の展望は？
- これらの主要企業の医薬品受託販売プロジェクトはどのようなものですか？
- 2020年から2032年にかけて、業界はどのように進化していくのか？現在および今後10年間に実施される医薬品受託販売プロジェクトはどのような意味を持つのか？
- 医薬品受託販売市場をさらに拡大させるために、製品の商業化の必要性は高まっているか？
- 医薬品受託販売市場はどこに向かい、どのようにすれば市場の最前線に立つことができるのか？
- 新製品やサービスラインに対する最適な投資オプションは？
- 企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望とは？

このことが、現在、そして今後10年間の医薬品受託販売市場にどのような影響を与えるかを見極める必要があります。

- 本レポートは365ページにわたり、174の表と202のグラフを掲載しています。
- このレポートでは、業界における主要な収益性の高い分野に焦点を当て、お客様が今すぐターゲットとできるような情報を提供しています。
- 世界、地域、国別の売上高と成長率を詳細に分析しています。
- 競合他社が成功した主要なトレンド、変化、収益予測をハイライトしています。

本レポートは、医薬品受託販売市場が今後10年間にどのように発展するか、またコビド19の景気後退と回復の変動に即してどのように発展するかを教えてくれるものです。この市場は、過去10年間のどの時点よりも、今がより重要です。

2032年までの予測やその他の分析により、商業的な展望が見えてくる
- 2032年までの収益予測に加え、直近の実績、成長率、市場シェアもご覧いただけます。
- ビジネスの展望や展開など、独自の分析もご覧いただけます。
- 定性的分析（市場ダイナミクス、ドライバー、機会、阻害要因、課題など）、コスト構造、医薬品受託販売価格上昇の影響、最近の開発状況などをご覧いただけます。

本レポートでは、COVID-19が業界と貴社にどのような影響を与えるかについて、データ分析と貴重な洞察を掲載しています。本レポートでは、COVID-19の4つの回収パターンとその影響、すなわち「V」、「L」、「W」、「U」について論じています。

報告書の対象セグメント

タイプ別市場セグメント
- パーソナルプロモーション
- ノンパーソナルプロモーション
- コプロモーション

パーソナルプロモーション別市場セグメント
- フィールドフォースの標準的な役割
- 営業展開
- 欠員補充
- HCP教育プログラム
- キーアカウントマネジメント
- その他パーソナルプロモーション

ノンパーソナルプロモーション別市場セグメント
- コンタクトセンター
- テレディテーリング
- メディカルコールセンター
- テレサンプリング
- オンラインサービス

治療薬別市場セグメント
- 循環器系疾患
- 代謝疾患
- 腫瘍学
- アルツハイマー型認知症
- 糖尿病
- その他の治療薬

マーケティングリサーチ・コンサルティング別市場セグメント
- 製品の商業化
- テリトリー最適化＆アライメント
- ブランドマネジメント
- マチュアプロダクトラインサポート
- その他のCSOサービス

世界市場全体とセグメントの収益予測に加え、4地域と主要20カ国市場の収益予測も掲載しています。

北米
- アメリカ
- カナダ

欧州
- ドイツ
- スペイン
- イギリス
- フランス
- イタリア
- その他の地域

アジア太平洋地域
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- その他のアジア太平洋地域

ラテンアメリカ
- ブラジル
- メキシコ
- その他のラテンアメリカ

中近東・アフリカ
- トルコ
- サウジアラビア
- 南米
- その他の中東・アフリカ

医薬品受託販売市場の2022年から2032年にかけての主要企業のプロファイルと、これらの企業のこのセグメントに焦点を当てた情報も掲載しています。

主要企業と市場成長の可能性
・ Amplity Health
・ Apodi Healthcare Limited
・ CMIC Holdings Co., Ltd
・ Granard Pharmaceuticals
・ GTS Solution
・ IQVIA Holdings Inc.
・ MaBiCo
・ Marvecs GmbH
・ OnCall LLC
・ Publicis Groupe SA
・ QFR Solutions
・ Sales Partnerships Inc.
・ Sofip SA
・ Syneos Health Inc.
・ UDG Healthcare PLC
・ Vanguard Pharma

医薬品受託販売市場の世界全体の収益、2022年から2032年まで金額ベースで、2022年に55億8940万米ドルを突破すると弊社は算出しています。2032年まで力強い収益成長が予測される。このレポートでは、最も大きな可能性を秘めた企業を特定しています。彼らの能力、進歩、商業的展望を知ることで、一歩先を行くことができます。

医薬品受託販売市場、2022年から2032年までのレポートはどのように役立つのでしょうか？
360ページを超えるレポートでは、要約すると以下のような知識を得ることができます。

- 医薬品受託販売市場、2022年から2032年までの収益予測タイプ、パーソナルプロモーション、非パーソナルプロモーション、マーケティングリサーチとコンサルティング、治療薬、企業規模、それぞれ世界と地域レベルで予測 - 投資と収益のための最も有利な場所を見つけ、業界の展望を発見してください。

- 4つの地域と20の主要国市場の2032年までの収益予測 - 北米、欧州、アジア太平洋、LAMEAの医薬品受託販売市場、2022年から2032年までの市場予測をご覧いただけます。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、中国、インド、日本、オーストラリアなどの主要経済圏の市場も予測されています。

- 既存企業および市場参入を目指す企業の展望 - 医薬品受託販売市場に関わる主要企業16社の企業プロファイルを含む、2022年から2032年までの展望。

定量的・定性的な分析と独自の予測をご覧いただけます。私たちのレポートだけが持つ情報を入手し、貴重なビジネスインテリジェンスを得ることができます。

他にはない情報
私たちの新しいレポートがあれば、知識の遅れを取り戻し、チャンスを逃す可能性が低くなります。私たちの研究が貴社の研究、分析、意思決定にどのように役立つかをご覧ください。Visiongainの調査は、医薬品受託販売市場、2022年から2032年、市場をリードする企業のための商業分析を必要とするすべての人のためのものです。データ、トレンド、予測をご覧いただけます。

ページTOPに戻る

1.レポートの概要
1.1 調査の目的
1.2 医薬品受託販売市場の紹介
1.3 本レポートが提供するもの
1.4 本レポートを読むべき理由
1.5 本分析報告書が回答する主な質問事項
1.6 本レポートは誰のためのものなのか？
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.8 よくある質問と回答（FAQ）
1.9 関連するVisiongainレポート
1.10 Visiongainについて

2 エグゼクティブサマリー
2.1 地域別スナップショット。医薬品受託販売の世界市場
2.2 タイプ別セグメント市場魅力度指標
2.3 パーソナル・プロモーション・セグメント市場魅力度指標
2.4 非パーソナル・プロモーション・セグメント市場魅力度指数
2.5 コ・プロモーションセグメント市場魅力度指標
2.6 治療薬セグメント市場魅力度指標

3 市場概要
3.1 市場のダイナミクス
3.1.1 市場の推進要因
3.1.2 市場の抑制要因
3.1.3 市場機会
3.2 バリューチェーン
3.2.1 医薬品バリューチェーン分析における主要活動
3.2.2 医薬品バリューチェーン分析における支援活動
3.3 COVID-19影響度分析
3.4 ポーターのファイブフォース分析
3.4.1 サプライヤーパワー(中)
3.4.2 バイヤーパワー(高)
3.4.3 競争相手との競合（高）
3.4.4 代替品の脅威 (低)
3.4.5 新規参入の脅威 (中程度)

4 世界の医薬品受託販売市場分析：タイプ別
4.1 主要な調査結果
4.2 世界市場の展望
4.3 タイプ別成長展望
4.4 医薬品受託販売の世界市場タイプ別シェア、2022年＆2032年
4.5 医薬品受託販売のタイプ別世界市場
4.6 パーソナルプロモーション
4.6.1 パーソナルプロモーションの世界市場予測、2022年～2032年
4.6.2 パーソナルプロモーションの世界市場予測（地域別）：2022年～2032年
4.7 ノン・パーソナル・プロモーション
4.7.1 ノン・パーソナルプロモーションの世界市場予測、2022年～2032年
4.7.2 ノン・パーソナル・プロモーションの世界市場予測：地域別、2022年～2032年
4.8 コ・プロモーション
4.8.1 コ・プロモーションの世界市場予測、2022年〜2032年
4.8.2 コ・プロモーションの世界市場予測：地域別、2022-2032年

5 世界の医薬品受託販売市場分析：パーソナルプロモーション別
5.1 主な調査結果
5.2 パーソナルプロモーション分野の成長展望
5.3 医薬品受託販売のパーソナルプロモーション別世界市場シェア（2022年＆2032年
5.4 パーソナルプロモーション別医薬品受託販売の世界市場
5.5 標準的なフィールドフォースチーム
5.5.1 標準的なフィールドフォースの役割の世界市場予測、2022年～2032年
5.5.2 標準フィールドフォースの地域別世界市場予測、2022年～2032年
5.6 セールス・デプロイメント
5.6.1 セールス・デプロイメントの世界市場予測、2022年～2032年
5.6.2 セールス・デプロイメントの世界地域別市場予測、2022-2032年
5.7 空室率
5.7.1 空室カバーの世界市場予測、2022-2032年
5.7.2 空席補償の世界市場予測：地域別、2022-2032年
5.8 HCP教育プログラム
5.8.1 HCP教育プログラムの世界市場予測：2022年〜2032年
5.8.2 HCP教育プログラムの世界市場予測：2022-2032年
5.9 キーアカウントマネジメント
5.9.1 キーアカウントマネジメントの世界市場予測、2022年～2032年
5.9.2 キーアカウントマネジメントの世界市場予測：2022-2032年
5.10 その他パーソナルプロモーション
5.10.1 その他のパーソナルプロモーションサービスの世界市場予測：2022年-2032年
5.10.2 その他のパーソナルプロモーションサービスの世界市場予測：2022年～2032年

6 世界の医薬品受託販売市場分析：ノンパーソナルプロモーション別
6.1 主な調査結果
6.2 セグメントの概要
6.3 ノンパーソナル・プロモーション・セグメントの成長展望
6.4 医薬品受託販売のノンパーソナルプロモーション別世界市場シェア、2022年＆2032年
6.5 医薬品受託販売の非パーソナルプロモーション別世界市場
6.6 コンタクトセンター
6.6.1 コンタクトセンターの世界市場予測、2022年～2032年
6.6.2 コンタクトセンターの世界地域別市場予測、2022年～2032年
6.7 テレディテイリング
6.7.1 テレディテイリングの世界市場予測、2022年～2032年
6.7.2 テレディテーリングの世界地域別市場予測、2022-2032年
6.8 メディカルコールセンター
6.8.1 メディカルコールセンターの世界市場予測、2022年〜2032年
6.8.2 メディカルコールセンターの世界市場予測：2022年～2032年
6.9 テレサンプリング
6.9.1 テレサンプリングの世界市場予測、2022年～2032年
6.9.2 テレサンプリングの世界市場予測（地域別）：2022年～2032年
6.10 オンラインサービス
6.10.1 オンラインサービスの世界市場予測、2022年〜2032年
6.10.2 オンラインサービスの世界市場予測、2022年〜2032年

7 世界の医薬品受託販売市場分析：コプロモーション別
7.1 主な調査結果
7.2 商業的側面
7.3 コプロモーション部門の成長展望
7.4 コプロモーションによる医薬品受託販売の世界市場シェア、2022年＆2032年
7.5 コ・プロモーションによる医薬品受託販売の世界市場
7.6 マーケティングリサーチとコンサルティング
7.6.1 マーケティングリサーチとコンサルティングの世界市場予測、2022年〜2032年
7.6.2 マーケティングリサーチとコンサルティングの世界地域別市場予測、2022年～2032年
7.7 製品の商業化
7.7.1 製品商業化の世界市場予測、2022年〜2032年
7.7.2 製品商業化の世界市場予測、2022-2032年
7.8 テリトリーオプティマイゼーション＆アライメント
7.8.1 テリトリー最適化＆アライメントの世界市場予測：2022年～2032年
7.8.2 テリトリー最適化＆アライメントの世界地域別市場予測、2022年～2032年
7.9 ブランドマネジメント
7.9.1 ブランドマネジメントの世界市場予測、2022年～2032年
7.9.2 ブランドマネジメントの世界市場予測、2022-2032年
7.10 マチュアプロダクトラインサポート
7.10.1 マチュアプロダクトラインサポートの世界市場予測、2022-2032年
7.10.2 マチュアプロダクトラインサポートの世界市場予測、2022年～2032年
7.11 レストオールCSOサービス
7.11.1 レストオールCSOサービスの世界市場予測：2022-2032年
7.11.2 休養型CSOサービスの世界地域別市場予測、2022-2032年

8 世界の医薬品受託販売市場分析：治療薬別
8.1 主な調査結果
8.2 商業的側面
8.3 治療薬セグメントの成長展望
8.4 医薬品受託販売の治療薬別世界市場シェア、2022年＆2032年
8.5 治療薬別医薬品販売受託の世界市場
8.6 循環器系疾患
8.6.1 循環器系疾患の世界市場予測、2022年〜2032年
8.6.2 循環器系疾患の世界地域別市場予測、2022年〜2032年
8.7 代謝性疾患
8.7.1 代謝性疾患の世界市場予測、2022年〜2032年
8.7.2 代謝性疾患の世界市場予測：地域別、2022年〜2032年
8.8 腫瘍学
8.8.1 オンコロジーの世界市場予測、2022-2032年
8.8.2 腫瘍学の世界市場地域別予測、2022-2032年
8.9 アルツハイマー型認知症
8.9.1 アルツハイマー病の世界市場予測、2022-2032年
8.9.2 アルツハイマー病の世界地域別市場予測、2022年〜2032年
8.10 糖尿病
8.10.1 糖尿病の世界市場予測、2022年〜2032年
8.10.2 糖尿病の世界市場予測（地域別）：2022年〜2032年
8.11 その他の治療薬
8.11.1 その他の治療薬の世界市場予測：2022年〜2032年
8.11.2 その他の治療薬の世界市場予測：2022-2032年

9 世界の医薬品受託販売市場分析：地域別
9.1 主要な調査結果
9.2 世界市場の展望
9.3 地域別の成長展望
9.4 医薬品受託販売の世界市場地域別シェア、2022年＆2032年
9.5 医薬品受託販売の世界市場規模の推定と予測
9.5.1 COVID-19前の市場シナリオ
9.5.2 ポストCOVID-19の市場シナリオ（V、W、U、L字回復の分析）
9.6 医薬品受託販売の世界市場規模予測・予測（地域別
9.6.1 COVID-19前の市場シナリオ
9.6.2 ポストCOVID-19市場シナリオ（V、W、U、L字回復分析）

10 北米の医薬品受託販売市場分析
10.1 主な調査結果
10.2 北米医薬品受託販売市場の魅力度指数
10.3 北米医薬品受託販売市場の金額別市場規模予測・予想
10.4 北米医薬品受託販売市場の国別市場規模予測・予測
10.5 北米医薬品受託販売市場のタイプ別市場規模予測・予想
10.6 北米医薬品受託販売の市場規模予測・予測：パーソナルプロモーション別
10.7 北米医薬品受託販売の市場規模予測・予測：非個人的プロモーション別
10.8 北米医薬品受託販売の市場規模予測・予測：コプロモーション別
10.9 北米医薬品契約販売の治療薬別市場規模予測・予測
10.10 米国
10.10.1 米国の医薬品受託販売市場：金額別
10.11 カナダ
10.11.1 カナダ医薬品受託販売市場：金額別

11 欧州の医薬品受託販売市場の分析
11.1 主な調査結果
11.2 欧州医薬品受託販売市場の魅力度指数
11.3 欧州医薬品受託販売市場の金額別市場規模予測・予測
11.4 欧州医薬品受託販売の国別市場規模予測・予測
11.5 欧州医薬品受託販売のタイプ別市場規模予測・予想
11.6 欧州医薬品受託販売の市場規模予測・予測：パーソナルプロモーション別
11.7 欧州医薬品受託販売の市場規模予測・予測：非個人的プロモーション別
11.8 欧州医薬品受託販売の市場規模予測・予測：コプロモーション別
11.9 欧州医薬品受託販売の治療薬別市場規模予測・予測
11.10 ドイツ
11.10.1 ドイツ医薬品契約販売市場：金額別
11.11 イギリス
11.11.1 イギリス医薬品受託販売市場：金額別
11.12 フランス
11.12.1 フランス医薬品受託販売市場：金額別
11.13 イタリア
11.13.1 イタリア医薬品受託販売事業の市場規模：金額別
11.14 スペイン
11.14.1 スペイン医薬品受託販売事業の市場規模：金額別
11.15 その他の地域
11.15.1 欧州の医薬品受託販売市場：金額別

12 アジア太平洋地域の医薬品受託販売市場の分析
12.1 主な調査結果
12.2 アジア太平洋地域の医薬品受託販売市場の魅力度指数
12.3 アジア太平洋地域の医薬品受託販売の市場規模予測・予測：金額別
12.4 アジア太平洋地域の医薬品受託販売市場の国別市場規模予測・予測
12.5 アジア太平洋地域の医薬品受託販売市場のタイプ別市場規模予測・予想
12.6 アジア太平洋地域の医薬品受託販売の市場規模予測・予測：パーソナルプロモーション別
12.7 アジア太平洋地域の医薬品受託販売の市場規模予測・予測：非個人的プロモーション別
12.8 アジア太平洋地域の医薬品受託販売の市場規模予測・予測：コプロモーション別
12.9 アジア太平洋地域の医薬品受託販売の治療薬別市場規模予測・予測
12.10 中国
12.10.1 中国医薬品受託販売市場：金額別
12.11 インド
12.11.1 インド医薬品契約販売市場：金額別
12.12 日本
12.12.1 日本医薬品受託販売市場：金額別
12.13 韓国
12.13.1 韓国医薬品受託販売事業の売上高市場：金額別
12.14 オーストラリア
12.14.1 オーストラリア医薬品受託販売事業の市場規模：金額別
12.15 その他のアジア太平洋地域
12.15.1 アジア太平洋地域の医薬品受託販売市場：金額別

13 中東・アフリカの医薬品受託販売市場分析
13.1 主な調査結果
13.2 中東・アフリカ医薬品受託販売市場の魅力度指数
13.3 中東・アフリカ医薬品受託販売市場の金額別市場規模予測・予想
13.4 中東・アフリカ医薬品受託販売市場の国別市場規模予測・予測
13.5 中東・アフリカ医薬品受託販売市場のタイプ別市場規模予測・予想
13.6 中東・アフリカ医薬品受託販売の市場規模予測・予測：パーソナルプロモーション別
13.7 中東・アフリカ医薬品受託販売の市場規模予測・予測：非個人的プロモーション別
13.8 中東・アフリカ医薬品受託販売の市場規模予測：コプロモーション別
13.9 中東・アフリカ医薬品受託販売の治療薬別市場規模予測・予想
13.10 南アフリカ
13.10.1 南アフリカの医薬品受託販売市場（金額別
13.11 サウジアラビア
13.11.1 サウジアラビアの医薬品受託販売市場：金額別
13.12 トルコ
13.12.1 トルコ医薬品受託販売事業の市場規模（金額別
13.13 その他のMEA地域
13.13.1 その他のMEA医薬品契約販売市場：金額別

14 南米の医薬品受託販売市場分析
14.1 主な調査結果
14.2 南米の医薬品受託販売市場の魅力度指数
14.3 南米の医薬品受託販売市場の金額別市場規模予測・予想
14.4 南米の医薬品受託販売市場の国別市場規模予測・予測
14.5 南米の医薬品受託販売市場のタイプ別市場規模予測・予想
14.6 南米の医薬品受託販売の市場規模予測・予測：パーソナルプロモーション別
14.7 南米の医薬品受託販売の市場規模予測・予測：非個人的プロモーション別
14.8 南米の医薬品受託販売の市場規模予測・予測：コプロモーション別
14.9 南米の医薬品受託販売の治療薬別市場規模予測・予測
14.10 ブラジル
14.10.1 ブラジル医薬品契約販売市場：金額別
14.11 メキシコ
14.11.1 メキシコ医薬品契約販売市場：金額別
14.12 南米その他
14.12.1 南米その他の地域医薬品受託販売市場：金額別

15 競合他社の状況
15.1 企業シェア分析
15.2 世界市場における主要な事業戦略としての新製品・サービス立ち上げ
15.3 グローバル市場における主要な事業戦略としての買収
15.4 グローバル市場における主要なビジネス戦略としてのパートナーシップ
15.5 グローバル市場における主要なビジネス戦略としてのコラボレーション
15.6 グローバル市場における主要なビジネス戦略としての事業拡大
15.7 グローバル市場における主要なビジネス戦略としての契約
15.8 グローバル市場における主要なビジネス戦略としての契約

16 主要企業のプロフィール
16.1 アポディ・ヘルスケア・リミテッド
16.1.1 会社概要
16.1.2 会社概要
16.1.3 製品ベンチマーク
16.2 シミックホールディングス
16.2.1 企業スナップショット
16.2.2 会社概要
16.2.3 財務分析
16.2.4 ベンチマーキング
16.2.5 戦略的展望
16.3 サイネオス・ヘルス社
16.3.1 企業スナップショット
16.3.2 会社概要
16.3.3 財務分析
16.3.4 製品ベンチマーク
16.3.5 戦略的展望
16.4 IQVIA Holdings Inc.
16.4.1 企業スナップショット
16.4.2 会社概要
16.4.3 財務分析
16.4.4 製品ベンチマーク
16.4.5 戦略的な展望
16.5 マーベックスGmbH
16.5.1 会社概要
16.5.2 会社概要
16.5.3 ベンチマーキング
16.6 オンコールLLC
16.6.1 企業スナップショット
16.6.2 会社概要
16.6.3 ベンチマーキング
16.7 ピュブリシスグループ
16.7.1 企業スナップショット
16.7.2 会社概要
16.7.3 財務分析
16.7.4 製品ベンチマーク
16.7.5 戦略的展望
16.8 ソフティップSA
16.8.1 企業スナップショット
16.8.2 会社概要
16.8.3 製品ベンチマーク
16.9 UDGヘルスケアPLC
16.9.1 企業スナップショット
16.9.2 会社概要
16.9.3 財務分析
16.9.4 ベンチマーキング
16.9.5 戦略的展望
16.10 アンプリティ・ヘルス
16.10.1 企業スナップショット
16.10.2 会社概要
16.10.3 製品ベンチマーク
16.10.4 戦略的展望
16.11 グラナード・ファーマシューティカルズ
16.11.1 企業スナップショット
16.11.2 会社概要
16.11.3 ベンチマーキング
16.12 ヴァンガード・ファーマ
16.12.1 企業スナップショット
16.12.2 会社概要
16.12.3 ベンチマーキング
16.13 GTS ソリューション
16.13.1 企業スナップショット
16.13.2 会社概要
16.13.3 ベンチマーキング
16.14 MaBiCo(販売受託機関)
16.14.1 企業スナップショット
16.14.2 会社概要
16.14.3 製品ベンチマーク
16.15 株式会社セールスパートナーシップス
16.15.1 企業スナップショット
16.15.2 会社概要
16.15.3 製品ベンチマーク
16.16 QFRソリューションズ
16.16.1 企業スナップショット
16.16.2 会社概要
16.16.3 ベンチマーキング

17 結論と提言
17.1 ヴィジョンゲインからの結論
17.2 市場関係者への提言

表の一覧
Table 1 Global Pharma Contract Sales Market Snapshot, 2022 & 2032 (US million, CAGR %)
Table 2 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 3 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 4 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 5 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 6 Global Pharma Contract Sales Market by Type, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 7 Global Personal Promotion Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 8 Global Personal Promotion Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 9 Global Non-Personal Promotion Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 10 Global Non-Personal Promotion Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 11 Global Co-Promotion Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 12 Global Co-Promotion Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 13 Global Pharma Contract Sales Market by Personal Promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 14 Global Standard Field Force Roles Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 15 Global Standard Field Force Roles Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 16 Global Sales Deployment Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 17 Global Sales Deployment Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 18 Global Vacancy Coverage Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 19 Global Vacancy Coverage Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 20 Global HCP Educational Programs Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 21 Global HCP Educational Programs Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 22 Global HCP Educational Programs Market by Region, 2022-2032 (US$ Million)
Table 23 Global Key Account Management Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 24 Global Key Account Management Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 25 Global Other Personal Promotion Services Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 26 Global Other Personal Promotion Services Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 27 Global Pharma Contract Sales Market by Non-Personal Promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 28 Global Contact Center Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 29 Global Contact Center Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 30 Global Tele-detailing Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 31 Global Tele-detailing Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 32 Global Medical Call Centers Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 33 Global Medical Call Centers Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 34 Global Tele-sampling Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 35 Global Tele-sampling Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 36 Global Online Services Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 37 Global Online Services Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 38 Global Pharma Contract Sales Market by Co-promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 39 Global Marketing Research and Consulting Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 40 Global Marketing Research and Consulting Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 41 Global Product Commercialization Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 42 Global Product Commercialization Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 43 Global Territory Optimization & Alignment Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 44 Global Territory Optimization & Alignment Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 45 Global Brand Management Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 46 Global Brand Management Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 47 Global Mature Product Line Support Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 48 Global Mature Product Line Support Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 49 Global Rest All CSO Services Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 50 Global Rest All CSO Services Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 51 Global Pharma Contract Sales Market by Therapeutics, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 52 Global Cardiovascular Disease Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 53 Global Cardiovascular Disease Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 54 Global Metabolic Disorders Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 55 Global Metabolic Disorders Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 56 Global Oncology Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 57 Global Oncology Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 58 Global Alzheimer's Disease Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 59 Global Alzheimer's Disease Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 60 Global Diabetes Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 61 Global Diabetes Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 62 Global Other Therapeutics Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 63 Global Other Therapeutics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 64 Global Pharma Contract Sales Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 65 Global Pharma Contract Sales Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 66 Global Pharma Contract Sales Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 67 Global Pharma Contract Sales Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 68 Global Pharma Contract Sales Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 69 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 70 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 71 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 72 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 73 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 74 North America Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 75 North America Pharma Contract Sales Market by Country, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 76 North America Pharma Contract Sales Market by Type, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 77 North America Pharma Contract Sales Market by Personal Promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 78 North America Pharma Contract Sales Market by Non-Personal Promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 79 North America Pharma Contract Sales Market by Co-promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 80 North America Pharma Contract Sales Market by Therapeutics, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 81 U.S. Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 82 Canada Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 83 Europe Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 84 Europe Pharma Contract Sales Market by Country, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 85 Europe Pharma Contract Sales Market by Type, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 86 Europe Pharma Contract Sales Market by Personal Promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 87 Europe Pharma Contract Sales Market by Non-Personal Promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 88 Europe Pharma Contract Sales Market by Co-promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 89 Europe Pharma Contract Sales Market by Therapeutics, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 90 Germany Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 91 UK Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 92 France Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 93 Italy Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 94 Spain Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 95 Rest of Europe Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 96 Asia-Pacific Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 97 Asia-Pacific Pharma Contract Sales Market by Country, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 98 Asia-Pacific Pharma Contract Sales Market by Type, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 99 Asia-Pacific Pharma Contract Sales Market by Personal Promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 100 Asia-Pacific Pharma Contract Sales Market by Non-Personal Promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 101 Asia-Pacific Pharma Contract Sales Market by Co-promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 102 Asia-Pacific Pharma Contract Sales Market by Therapeutics, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 103 China Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 104 India Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 105 Japan Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 106 South Korea Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 107 Australia Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 108 Rest of Asia-Pacific Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 109 Middle East & Africa Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 110 Middle East & Africa Pharma Contract Sales Market by Country, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 111 Middle East & Africa Pharma Contract Sales Market by Type, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 112 Middle East & Africa Pharma Contract Sales Market by Personal Promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 113 Middle East & Africa Pharma Contract Sales Market by Non-Personal Promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 114 Middle East & Africa Pharma Contract Sales Market by Co-promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 115 Middle East & Africa Pharma Contract Sales Market by Therapeutics, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 116 South Africa Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 117 Saudi Arabia Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 118 Turkey Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 119 Rest of Middle East & Africa Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 120 South America Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 121 South America Pharma Contract Sales Market by Country, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 122 South America Pharma Contract Sales Market by Type, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 123 South America Pharma Contract Sales Market by Personal Promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 124 South America Pharma Contract Sales Market by Non-Personal Promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 125 South America Pharma Contract Sales Market by Co-promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 126 South America Pharma Contract Sales Market by Therapeutics, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 127 Brazil Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 128 Mexico Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 129 Rest of South America Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 130 New Product Launch Business Strategies Adopted by Key Players in Global Pharma Contract Sales Market
Table 131 Acquisition Business Strategies Adopted by Key Players in Global Pharma Contract Sales Market
Table 132 Partnership Strategy Adopted by Key Players in Global Pharma Contract Sales Market, 2018-2021
Table 133 Collaboration Business Strategies Adopted by Key Players in Global Pharma Contract Sales Market
Table 134 Expansion Business Strategies Adopted by Key Players in Global Pharma Contract Sales Market
Table 135 Agreement Business Strategies Adopted by Key Players in Global Pharma Contract Sales Market
Table 136 Contract Business Strategies Adopted by Key Players in Global Pharma Contract Sales Market
Table 137 Apodi Healthcare Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 138 Apodi Healthcare Limited: Product Benchmarking
Table 139 CMIC Holdings Co., Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 140 CMIC Holdings Co., Ltd: Product Benchmarking
Table 141 CMIC Holdings Co., Ltd: Strategic Outlook
Table 142 Syneos Health Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 143 Syneos Health Inc.: Product Benchmarking
Table 144 Syneos Health Inc.: Strategic Outlook
Table 145 IQVIA Holdings Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 146 IQVIA Holdings Inc.: Product Benchmarking
Table 147 IQVIA Holdings Inc.: Strategic Outlook
Table 148 Marvecs GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 149 Marvecs GmbH: Product Benchmarking
Table 150 OnCall LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 151 OnCall LLC: Product Benchmarking
Table 152 Publicis Groupe SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 153 Publicis Groupe SA: Product Benchmarking
Table 154 Publicis Groupe SA: Strategic Outlook
Table 155 Sofip SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 156 Sofip SA: Product Benchmarking
Table 157 UDG Healthcare PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 158 UDG Healthcare PLC: Product Benchmarking
Table 159 UDG Healthcare PLC: Strategic Outlook
Table 160 Amplity Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 161 Amplity Health: Product Benchmarking
Table 162 Amplity Health: Strategic Outlook
Table 163 Granard Pharmaceuticals: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 164 Granard Pharmaceuticals: Product Benchmarking
Table 165 Vanguard Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 166 Vanguard Pharma: Product Benchmarking
Table 167 GTS Solution: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 168 GTS Solution: Product Benchmarking
Table 169 MaBiCo (Contract Sales Organization): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 170 MaBiCo (Contract Sales Organization): Product Benchmarking
Table 171 Sales Partnerships Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 172 Sales Partnerships Inc.: Product Benchmarking
Table 173 QFR Solutions: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 174 QFR Solutions: Product Benchmarking

図の一覧
Figure 1 Global Pharma Contract Sales Market Segmentation
Figure 2 Global Pharma Contract Sales Market Forecast by Region: Market Attractiveness Index
Figure 3 Global Pharma Contract Sales Market by Type: Market Attractiveness Index
Figure 4 Global Pharma Contract Sales Market by Personal Promotion: Market Attractiveness Index
Figure 5 Global Pharma Contract Sales Market by Non-Personal Promotion: Market Attractiveness Index
Figure 6 Global Pharma Contract Sales Market by Co-promotion: Market Attractiveness Index
Figure 7 Global Pharma Contract Sales Market by Therapeutics: Market Attractiveness Index
Figure 8 Global Pharma Contract Sales Market: Market Dynamics
Figure 9 Global COVID Impact Analysis: Pharma Contract Sales Market Recovery Scenarios
Figure 10 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%)): “V” Shaped Recovery
Figure 11 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%)): “U” Shaped Recovery
Figure 12 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%)): “W” Shaped Recovery
Figure 13 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%)): “L” Shaped Recovery
Figure 14 Global Pharma Contract Sales Market: Porter’s Five Forces Analysis
Figure 15 Global Pharma Contract Sales Market Forecast by Type 2022, 2027, 2032 (Revenue, CAGR%)
Figure 16 Global Pharma Contract Sales Market Forecast by Type 2022, 2032 (Revenue, CAGR%)
Figure 17 Global Pharma Contract Sales Market by Type, 2022-2032 (US$ Million)
Figure 18 Global Personal Promotion Market Forecast, 2022-2032 (US$ Million)
Figure 19 Global Personal Promotion Market by Region, 2022-2032 (US$ Million)
Figure 20 Global Non-Personal Promotion Market Forecast, 2022-2032 (US$ Million)
Figure 21 Global Non-Personal Promotion Market by Region, 2022-2032 (US$ Million)
Figure 22 Global Co-Promotion Market Forecast, 2022-2032 (US$ Million)
Figure 23 Global Co-Promotion Market by Region, 2022-2032 (US$ Million)
Figure 24 Global Pharma Contract Sales Market Forecast by Personal Promotion 2022, 2027, 2032 (Revenue, CAGR%)
Figure 25 Global Pharma Contract Sales Market Forecast by Personal Promotion 2022, 2032 (Revenue, CAGR%)
Figure 26 Global Pharma Contract Sales Market by Personal Promotion, 2022-2032 (US$ Million)
Figure 27 Global Standard Field Force Roles Market Forecast, 2022-2032 (US$ Million)
Figure 28 Global Standard Field Force Roles Market by Region, 2022-2032 (US$ Million)
Figure 29 Global Sales Deployment Market Forecast, 2022-2032 (US$ Million)
Figure 30 Global Sales Deployment Market by Region, 2022-2032 (US$ Million)
Figure 31 Global Vacancy Coverage Market Forecast, 2022-2032 (US$ Million)
Figure 32 Global Vacancy Coverage Market by Region, 2022-2032 (US$ Million)
Figure 33 Global HCP Educational Programs Market Forecast, 2022-2032 (US$ Million)
Figure 34 Global HCP Educational Programs Market by Region, 2022-2032 (US$ Million)
Figure 35 Global Key Account Management Market Forecast, 2022-2032 (US$ Million)
Figure 36 Global Key Account Management Market by Region, 2022-2032 (US$ Million)
Figure 37 Global Other Personal Promotion Services Market Forecast, 2022-2032 (US$ Million)
Figure 38 Global Other Personal Promotion Services Market by Region, 2022-2032 (US$ Million)
Figure 39 Global Pharma Contract Sales Market Forecast by Non-Personal Promotion 2022, 2027, 2032 (Revenue, CAGR%)
Figure 40 Global Pharma Contract Sales Market Forecast by Non-Personal Promotion 2022, 2032 (Revenue, CAGR%)
Figure 41 Global Pharma Contract Sales Market by Non-Personal Promotion, 2022-2032 (US$ Million)
Figure 42 Global Contact Center Market Forecast, 2022-2032 (US$ Million)
Figure 43 Global Contact Center Market by Region, 2022-2032 (US$ Million)
Figure 44 Global Tele-detailing Market Forecast, 2022-2032 (US$ Million)
Figure 45 Global Tele-detailing Market by Region, 2022-2032 (US$ Million)
Figure 46 Global Medical Call Centers Market Forecast, 2022-2032 (US$ Million)
Figure 47 Global Medical Call Centers Market by Region, 2022-2032 (US$ Million)
Figure 48 Global Tele-sampling Market Forecast, 2022-2032 (US$ Million)
Figure 49 Global Tele-sampling Market by Region, 2022-2032 (US$ Million)
Figure 50 Global Online Services Market Forecast, 2022-2032 (US$ Million)
Figure 51 Global Online Services Market by Region, 2022-2032 (US$ Million)
Figure 52 Global Pharma Contract Sales Market Forecast by Co-Promotion 2022, 2027, 2032 (Revenue, CAGR%)
Figure 53 Global Pharma Contract Sales Market Forecast by Co-Promotion 2022, 2032 (Revenue, CAGR%)
Figure 54 Global Pharma Contract Sales Market by Co-Promotion, 2022-2032 (US$ Million)
Figure 55 Global Marketing Research and Consulting Market Forecast, 2022-2032 (US$ Million)
Figure 56 Global Marketing Research and Consulting Market by Region, 2022-2032 (US$ Million)
Figure 57 Global Product Commercialization Market Forecast, 2022-2032 (US$ Million)
Figure 58 Global Product Commercialization Market by Region, 2022-2032 (US$ Million)
Figure 59 Global Territory Optimization & Alignment Market Forecast, 2022-2032 (US$ Million)
Figure 60 Global Territory Optimization & Alignment Market by Region, 2022-2032 (US$ Million)
Figure 61 Global Brand Management Market Forecast, 2022-2032 (US$ Million)
Figure 62 Global Brand Management Market by Region, 2022-2032 (US$ Million)
Figure 63 Global Mature Product Line Support Market Forecast, 2022-2032 (US$ Million, AGR (%))
Figure 64 Global Mature Product Line Support Market by Region, 2022-2032 (US$ Million)
Figure 65 Global Rest All CSO Services Market Forecast, 2022-2032 (US$ Million, AGR (%))
Figure 66 Global Rest All CSO Services Market by Region, 2022-2032 (US$ Million)
Figure 67 Global Pharma Contract Sales Market Forecast by Therapeutics 2022, 2027, 2032 (Revenue, CAGR%)
Figure 68 Global Pharma Contract Sales Market Forecast by Therapeutics 2022, 2032 (Revenue, CAGR (%))
Figure 69 Global Pharma Contract Sales Market by Therapeutics, 2022-2032 (US$ Million)
Figure 70 Global Cardiovascular Disease Market Forecast, 2022-2032 (US$ Million)
Figure 71 Global Cardiovascular Disease Market by Region, 2022-2032 (US$ Million)
Figure 72 Global Metabolic Disorders Market Forecast, 2022-2032 (US$ Million)
Figure 73 Global Metabolic Disorders Market by Region, 2022-2032 (US$ Million)
Figure 74 Global Oncology Market Forecast, 2022-2032 (US$ Million)
Figure 75 Global Oncology Market by Region, 2022-2032 (US$ Million)
Figure 76 Global Alzheimer's Disease Market Forecast, 2022-2032 (US$ Million)
Figure 77 Global Alzheimer's Disease Market by Region, 2022-2032 (US$ Million)
Figure 78 Global Diabetes Market Forecast, 2022-2032 (US$ Million)
Figure 79 Global Diabetes Market by Region, 2022-2032 (US$ Million)
Figure 80 Global Other Therapeutics Market Forecast, 2022-2032 (US$ Million)
Figure 81 Global Other Therapeutics Market by Region, 2022-2032 (US$ Million)
Figure 82 Global Pharma Contract Sales Market Forecast by Region 2022, 2027, 2032 (Revenue, CAGR%)
Figure 83 Global Pharma Contract Sales Market Forecast by Region 2022, 2032 (Revenue, CAGR%)
Figure 84 Global Pharma Contract Sales Market Forecast, 2022-2032 (US$ Million, AGR (%))
Figure 85 Global Pharma Contract Sales Market Forecast, 2021-2031 (US$ Million, AGR (%)) (V-Shape Recovery)
Figure 86 Global Pharma Contract Sales Market Forecast, 2021-2031 (US$ Million, AGR (%)) (W-Shape Recovery)
Figure 87 Global Pharma Contract Sales Market Forecast, 2021-2031 (US$ Million, AGR (%)) (U-Shape Recovery)
Figure 88 Global Pharma Contract Sales Market Forecast, 2021-2031 (US$ Million, AGR (%)) (L-Shape Recovery)
Figure 89 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%))
Figure 90 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%)) (V-Shaped Recovery Scenario)
Figure 91 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%)) (W-Shaped Recovery Scenario)
Figure 92 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%)) (U-Shaped Recovery Scenario)
Figure 93 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%)) (L-Shaped Recovery Scenario)
Figure 94 North America Pharma Contract Sales Market Attractiveness Index
Figure 95 North America Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%))
Figure 96 North America Pharma Contract Sales Market Forecast by Country, 2022-2032 (US$ Million, AGR %)
Figure 97 North America Pharma Contract Sales Market Share Forecast by Country, 2022 & 2032 (%)
Figure 98 North America Pharma Contract Sales Market Forecast by Type, 2022-2032 (US$ Million, AGR %)
Figure 99 North America Pharma Contract Sales Market Share Forecast by Type, 2022 & 2032 (%)
Figure 100 North America Pharma Contract Sales Market Forecast by Personal Promotion, 2022-2032 (US$ Million, AGR %)
Figure 101 North America Pharma Contract Sales Market Share Forecast by Personal Promotion, 2022 & 2032 (%)
Figure 102 North America Pharma Contract Sales Market Forecast by Non-Personal Promotion, 2022-2032 (US$ Million, AGR %)
Figure 103 North America Pharma Contract Sales Market Share Forecast by Non-Personal Promotion, 2022 & 2032 (%)
Figure 104 North America Pharma Contract Sales Market Forecast by Co-Promotion, 2022-2032 (US$ Million, AGR %)
Figure 105 North America Pharma Contract Sales Market Share Forecast by Co-Promotion, 2022 & 2032 (%)
Figure 106 North America Pharma Contract Sales Market Forecast by Therapeutics, 2022-2032 (US$ Million, AGR %)
Figure 107 North America Pharma Contract Sales Market Share Forecast by Therapeutics, 2022 & 2032 (%)
Figure 108 U.S. Pharma Contract Sales Market Forecast, 2022-2032 (US$ Million, AGR %)
Figure 109 Canada Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 110 Europe Pharma Contract Sales Market Attractiveness Index
Figure 111 Europe Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%))
Figure 112 Europe Pharma Contract Sales Market Forecast by Country, 2022-2032 (US$ Million, AGR %)
Figure 113 Europe Pharma Contract Sales Market Share Forecast by Country, 2022 & 2032 (%)
Figure 114 Europe Pharma Contract Sales Market Forecast by Type, 2022-2032 (US$ Million, AGR %)
Figure 115 Europe Pharma Contract Sales Market Share Forecast by Type, 2022 & 2032 (%)
Figure 116 Europe Pharma Contract Sales Market Forecast by Personal Promotion, 2022-2032 (US$ Million, AGR %)
Figure 117 Europe Pharma Contract Sales Market Share Forecast by Personal Promotion, 2022 & 2032 (%)
Figure 118 Europe Pharma Contract Sales Market Forecast by Non-Personal Promotion, 2022-2032 (US$ Million, AGR %)
Figure 119 Europe Pharma Contract Sales Market Share Forecast by Non-Personal Promotion, 2022 & 2032 (%)
Figure 120 Europe Pharma Contract Sales Market Forecast by Co-Promotion, 2022-2032 (US$ Million, AGR %)
Figure 121 Europe Pharma Contract Sales Market Share Forecast by Co-Promotion, 2022 & 2032 (%)
Figure 122 North America Pharma Contract Sales Market Forecast by Therapeutics, 2022-2032 (US$ Million, AGR %)
Figure 123 Europe Pharma Contract Sales Market Share Forecast by Therapeutics, 2022 & 2032 (%)
Figure 124 Germany Pharma Contract Sales Market Forecast, 2022-2032 (US$ Million, AGR %)
Figure 125 UK Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 126 France Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 127 Italy Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 128 Spain Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 129 Rest of Europe Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 130 Asia-Pacific Pharma Contract Sales Market Attractiveness Index
Figure 131 Asia-Pacific Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%))
Figure 132 Asia-Pacific Pharma Contract Sales Market Forecast by Country, 2022-2032 (US$ Million, AGR %)
Figure 133 Asia-Pacific Pharma Contract Sales Market Share Forecast by Country, 2022 & 2032 (%)
Figure 134 Asia-Pacific Pharma Contract Sales Market Forecast by Type, 2022-2032 (US$ Million, AGR %)
Figure 135 Asia-Pacific Pharma Contract Sales Market Share Forecast by Type, 2022 & 2032 (%)
Figure 136 Asia-Pacific Pharma Contract Sales Market Forecast by Personal Promotion, 2022-2032 (US$ Million, AGR %)
Figure 137 Asia-Pacific Pharma Contract Sales Market Share Forecast by Personal Promotion, 2022 & 2032 (%)
Figure 138 Asia-Pacific Pharma Contract Sales Market Forecast by Non-Personal Promotion, 2022-2032 (US$ Million, AGR %)
Figure 139 Asia-Pacific Pharma Contract Sales Market Share Forecast by Non-Personal Promotion, 2022 & 2032 (%)
Figure 140 Asia-Pacific Pharma Contract Sales Market Forecast by Co-Promotion, 2022-2032 (US$ Million, AGR %)
Figure 141 Asia-Pacific Pharma Contract Sales Market Share Forecast by Co-Promotion, 2022 & 2032 (%)
Figure 142 Asia-Pacific Pharma Contract Sales Market Forecast by Therapeutics, 2022-2032 (US$ Million, AGR %)
Figure 143 Asia-Pacific Pharma Contract Sales Market Share Forecast by Therapeutics, 2022 & 2032 (%)
Figure 144 China Pharma Contract Sales Market Forecast, 2022-2032 (US$ Million, AGR %)
Figure 145 India Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 146 Japan Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 147 South Korea Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 148 Australia Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 149 Rest of Asia-Pacific Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 150 Middle East & Africa Pharma Contract Sales Market Attractiveness Index
Figure 151 Middle East & Africa Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%))
Figure 152 Middle East & Africa Pharma Contract Sales Market Forecast by Country, 2022-2032 (US$ Million, AGR %)
Figure 153 Middle East & Africa Pharma Contract Sales Market Share Forecast by Country, 2022 & 2032 (%)
Figure 154 Middle East & Africa Pharma Contract Sales Market Forecast by Type, 2022-2032 (US$ Million, AGR %)
Figure 155 Middle East & Africa Pharma Contract Sales Market Share Forecast by Type, 2022 & 2032 (%)
Figure 156 Middle East & Africa Pharma Contract Sales Market Forecast by Personal Promotion, 2022-2032 (US$ Million, AGR %)
Figure 157 Middle East & Africa Pharma Contract Sales Market Share Forecast by Personal Promotion, 2022 & 2032 (%)
Figure 158 Middle East & Africa Pharma Contract Sales Market Forecast by Non-Personal Promotion, 2022-2032 (US$ Million, AGR %)
Figure 159 Middle East & Africa Pharma Contract Sales Market Share Forecast by Non-Personal Promotion, 2022 & 2032 (%)
Figure 160 Middle East & Africa Pharma Contract Sales Market Forecast by Co-Promotion, 2022-2032 (US$ Million, AGR %)
Figure 161 Middle East & Africa Pharma Contract Sales Market Share Forecast by Co-Promotion, 2022 & 2032 (%)
Figure 162 Middle East & Africa Pharma Contract Sales Market Forecast by Therapeutics, 2022-2032 (US$ Million, AGR %)
Figure 163 Middle East & Africa Pharma Contract Sales Market Share Forecast by Therapeutics, 2022 & 2032 (%)
Figure 164 South Africa Pharma Contract Sales Market Forecast, 2022-2032 (US$ Million, AGR %)
Figure 165 Saudi Arabia Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 166 Turkey Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 167 Saudi Arabia Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 168 South America Pharma Contract Sales Market Attractiveness Index
Figure 169 South America Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%))
Figure 170 South America Pharma Contract Sales Market Forecast by Country, 2022-2032 (US$ Million, AGR %)
Figure 171 South America Pharma Contract Sales Market Share Forecast by Country, 2022 & 2032 (%)
Figure 172 South America Pharma Contract Sales Market Forecast by Type, 2022-2032 (US$ Million, AGR %)
Figure 173 South America Pharma Contract Sales Market Share Forecast by Type, 2022 & 2032 (%)
Figure 174 South America Pharma Contract Sales Market Forecast by Personal Promotion, 2022-2032 (US$ Million, AGR %)
Figure 175 South America Pharma Contract Sales Market Share Forecast by Personal Promotion, 2022 & 2032 (%)
Figure 176 South America Pharma Contract Sales Market Forecast by Non-Personal Promotion, 2022-2032 (US$ Million, AGR %)
Figure 177 South America Pharma Contract Sales Market Share Forecast by Non-Personal Promotion, 2022 & 2032 (%)
Figure 178 South America Pharma Contract Sales Market Forecast by Co-Promotion, 2022-2032 (US$ Million, AGR %)
Figure 179 South America Pharma Contract Sales Market Share Forecast by Co-Promotion, 2022 & 2032 (%)
Figure 180 South America Pharma Contract Sales Market Forecast by Therapeutics, 2022-2032 (US$ Million, AGR %)
Figure 181 South America Pharma Contract Sales Market Share Forecast by Therapeutics, 2022 & 2032 (%)
Figure 182 Brazil Pharma Contract Sales Market Forecast, 2022-2032 (US$ Million, AGR %)
Figure 183 Mexico Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 184 Rest of South America Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 185 Global Pharma Contract Sales Market: Company Share Analysis, 2021
Figure 186 CMIC Holdings Co., Ltd: Net Revenue, 2017-2021 (US$ Million, AGR%)
Figure 187 CMIC Holdings Co., Ltd: Gross Profit, 2017-2021 (US$ Million, AGR%)
Figure 188 CMIC Holdings Co., Ltd: R&D, 2017-2021 (US$ Million, AGR%)
Figure 189 CMIC Holdings Co., Ltd: EBITDA, 2017-2021 (US$ Million, AGR%)
Figure 190 Syneos Health Inc.: Net Revenue, 2017-2021 (US$ Million, AGR%)
Figure 191 Syneos Health Inc.: Gross Profit, 2017-2021 (US$ Million, AGR%)
Figure 192 Syneos Health Inc.: EBITDA, 2017-2021 (US$ Million, AGR%)
Figure 193 IQVIA Holdings Inc.: Net Revenue, 2017-2021 (US$ Million, AGR%)
Figure 194 IQVIA Holdings Inc.: Gross Profit, 2017-2021 (US$ Million, AGR%)
Figure 195 IQVIA Holdings Inc.: EBITDA, 2017-2021 (US$ Million, AGR%)
Figure 196 Publicis Groupe SA: Net Revenue, 2017-2021 (US$ Million, AGR%)
Figure 197 Publicis Groupe SA: Gross Profit, 2017-2021 (US$ Million, AGR%)
Figure 198 Publicis Groupe SA: EBITDA, 2017-2021 (US$ Million, AGR%)
Figure 199 UDG Healthcare PLC: Net Revenue, 2017-2021 (US$ Million, AGR%)
Figure 200 UDG Healthcare PLC: Gross Profit, 2017-2021 (US$ Million, AGR%)
Figure 201 UDG Healthcare PLC: R&D, 2017-2021 (US$ Million, AGR%)
Figure 202 UDG Healthcare PLC: EBITDA, 2017-2021 (US$ Million, AGR%)

ページTOPに戻る

Table of Contents

Summary

この調査レポートは世界の医薬品受託販売市場を調査し、タイプ別、パーソナルプロモーション別、ノンパーソナルプロモーション別、治療薬別、マーケティングリサーチ・コンサルティング別、地域別に2022年から2032年までの予測結果を掲載しています。また関連企業情報を提供しています。

主な掲載内容（目次より抜粋）

レポート概要
エグゼクティブサマリー
市場概要
世界の医薬品受託販売市場分析：タイプ別
世界の医薬品受託販売市場分析：パーソナルプロモーション別
世界の医薬品受託販売市場分析：ノンパーソナルプロモーション別
世界の医薬品受託販売市場分析：コプロモーション別
世界の医薬品受託販売市場分析：治療薬別
世界の医薬品受託販売市場分析：地域別
北米の医薬品受託販売市場分析
欧州の医薬品受託販売市場分析
アジア太平洋地域の医薬品受託販売市場分析
中東・アフリカの医薬品受託販売市場分析
南米の医薬品受託販売市場分析
競争状況
主要企業のプロフィール

Report Details

The Pharma Contract Sales Market Report 2022-2032: If leading businesses are looking for new sources of income and want to understand the market and its underlying dynamics, this report will be invaluable. It will be helpful for businesses looking to diversify into new markets or increase the scope of their current operations.

Increasing R&D in Pharmaceutical Companies Has Changed Outsourcing Dynamics
Many medium-sized and large pharmaceutical businesses are outsourcing their operations because it offers cost control, better results, and operational flexibility in response to rising R&D and other operating costs in the pharmaceutical industry. CSOs offer experience with market access, health authorities, and local account management, which has contributed to an increase in the number of CSOs in recent years and is anticipated to continue in the near future. CSOs in Europe account for about one-third of pharmaceutical officials. Few CSOs do, however, provide their potentially contentious sales and marketing services to diverse businesses operating in the same region.

Quality Abandonment in Pharmaceutical Sales and Services
The contract manufacturer’s attempt to secure orders from as many pharmaceutical companies as possible is the sole issue. As a result, it strives to receive as many orders from its computers each day as feasible. When anything reaches its potential, quality must inevitably suffer. After doing a thorough study, this anxiety can be reduced by getting in touch with the proper contract manufacturing business. Pharmaceutical quality is influenced by a variety of factors, some of which can compound one another, including raw ingredients, manufacturing procedures, packaging, transit, and storage conditions.

What Questions Should You Ask before Buying a Market Research Report?
• How is the pharma contract sales market evolving?
• What is driving and restraining the pharma contract sales market?
• How will each pharma contract sales submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each pharma contract sales submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading pharma contract sales markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the pharma contract sales projects for these leading companies?
• How will the industry evolve during the period between 2020 and 2032? What are the implications of pharma contract sales projects taking place now and over the next 10 years?
• Is there a greater need for product commercialization to further scale the pharma contract sales market?
• Where is the pharma contract sales market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the pharma contract sales market today, and over the next 10 years:
• Our 365-page report provides 174 tables and 202 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains an in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes, and revenue projections made by your competitors.

This report tells you TODAY how the pharma contract sales market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2032 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising pharma contract sales prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Market Segment by Type
• Personal Promotion
• Non-Personal Promotion
• Co-Promotion

Market Segment by Personal Promotion
• Standard Field Force Roles
• Sales Deployment
• Vacancy Coverage
• HCP Educational Programs
• Key Account Management
• Other Personal Promotion Services

Market Segment by Non-Personal Promotion
• Contact Center
• Tele-detailing
• Medical Call Centers
• Telesampling
• Online Services

Market Segment by Therapeutics
• Cardiovascular Disease
• Metabolic Disorders
• Oncology
• Alzheimer’s Disease
• Diabetes
• Other Therapeutics

Market Segment by Marketing Research and Consulting
• Product Commercialization
• Territory Optimization & Alignment
• Brand Management
• Mature Product Line Support
• Rest All CSO Services

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• Spain
• United Kingdom
• France
• Italy
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa
• Turkey
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

The report also includes profiles and for some of the leading companies in the Pharma Contract Sales Market, 2022 to 2032, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Amplity Health
• Apodi Healthcare Limited
• CMIC Holdings Co., Ltd
• Granard Pharmaceuticals
• GTS Solution
• IQVIA Holdings Inc.
• MaBiCo
• Marvecs GmbH
• OnCall LLC
• Publicis Groupe SA
• QFR Solutions
• Sales Partnerships Inc.
• Sofip SA
• Syneos Health Inc.
• UDG Healthcare PLC
• Vanguard Pharma

Overall world revenue for Pharma Contract Sales Market, 2022 to 2032 in terms of value the market will surpass US$5,589.4 million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Pharma Contract Sales Market, 2022 to 2032 report help you?
In summary, our 360+ page report provides you with the following knowledge:

• Revenue forecasts to 2032 for Pharma Contract Sales Market, 2022 to 2032 Market, with forecasts for type, Personal Promotion, non- Personal Promotion, Marketing Research and Consulting, Therapeutics and company size, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2032 for four regional and 20 key national markets – See forecasts for the Pharma Contract Sales Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 16 of the major companies involved in the Pharma Contract Sales Market, 2022 to 2032.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Pharma Contract Sales Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.

ページTOPに戻る

Table of Contents

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Pharma Contract Sales Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary
2.1 Geographical Snapshot: Global Pharma Contract Sales Market
2.2 Type Segment: Market Attractiveness Index
2.3 Personal Promotion Segment: Market Attractiveness Index
2.4 Non-Personal Promotion Segment: Market Attractiveness Index
2.5 Co-promotion Segment: Market Attractiveness Index
2.6 Therapeutics Segment: Market Attractiveness Index

3 Market Overview
3.1 Market Dynamics
3.1.1 Market Driving Factors
3.1.2 Market Restraining Factors
3.1.3 Market Opportunities
3.2 Value Chain
3.2.1 Primary Activities in Pharmaceutical Value Chain Analysis
3.2.2 Support Activities in the Analysis of the Pharmaceutical Value Chain
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Supplier Power (Moderate)
3.4.2 Buyer Power (High)
3.4.3 Competitive Rivalry (High)
3.4.4 Threat from Substitutes (Low)
3.4.5 Threat of New Entrants (Moderate)

4 Global Pharma Contract Sales Market Analysis by Type
4.1 Key Findings
4.2 Global Market Outlook
4.3 Type Segment Growth Prospects
4.4 Global Pharma Contract Sales Market Share by Type, 2022 & 2032
4.5 Global Pharma Contract Sales Market by Type
4.6 Personal Promotion
4.6.1 Global Personal Promotion Market Forecast, 2022-2032
4.6.2 Global Personal Promotion Market Forecast by Region, 2022-2032
4.7 Non-Personal Promotion
4.7.1 Global Non-Personal Promotion Market Forecast, 2022-2032
4.7.2 Global Non-Personal Promotion Market Forecast by Region, 2022-2032
4.8 Co-Promotion
4.8.1 Global Co-Promotion Market Forecast, 2022-2032
4.8.2 Global Co-Promotion Market Forecast by Region, 2022-2032

5 Global Pharma Contract Sales Market Analysis by Personal Promotion
5.1 Key Findings
5.2 Personal Promotion Segment Growth Prospects
5.3 Global Pharma Contract Sales Market Share by Personal Promotion, 2022 & 2032
5.4 Global Pharma Contract Sales Market by Personal Promotion
5.5 Standard Field Force Teams
5.5.1 Global Standard Field Force Roles Market Forecast, 2022-2032
5.5.2 Global Standard Field Force Roles Market by Region Forecast, 2022-2032
5.6 Sale Deployment
5.6.1 Global Sales Deployment Market Forecast, 2022-2032
5.6.2 Global Sales Deployment Market by Region Forecast, 2022-2032
5.7 Vacancy Coverage
5.7.1 Global Vacancy Coverage Market Forecast, 2022-2032
5.7.2 Global Vacancy Coverage Market by Region Forecast, 2022-2032
5.8 HCP Educational Programs
5.8.1 Global HCP Educational Programs Market Forecast, 2022-2032
5.8.2 Global HCP Educational Programs Market by Region Forecast, 2022-2032
5.9 Key Account Management
5.9.1 Global Key Account Management Market Forecast, 2022-2032
5.9.2 Global Key Account Management Market by Region Forecast, 2022-2032
5.10 Other Personal Promotion
5.10.1 Global Other Personal Promotion Services Market Forecast, 2022-2032
5.10.2 Global Other Personal Promotion Services Market by Region Forecast, 2022-2032

6 Global Pharma Contract Sales Market Analysis by Non-Personal Promotion
6.1 Key Findings
6.2 Segment Overview
6.3 Non-Personal Promotion Segment Growth Prospects
6.4 Global Pharma Contract Sales Market Share by Non-Personal Promotion, 2022 & 2032
6.5 Global Pharma Contract Sales Market by Non-Personal Promotion
6.6 Contact Center
6.6.1 Global Contact Centre Market Forecast, 2022-2032
6.6.2 Global Contact Centre Market by Region Forecast, 2022-2032
6.7 Tele-Detailing
6.7.1 Global Tele-detailing Market Forecast, 2022-2032
6.7.2 Global Tele-detailing Market by Region Forecast, 2022-2032
6.8 Medical Call Center
6.8.1 Global Medical Call Centres Market Forecast, 2022-2032
6.8.2 Global Medical Call Centres Market by Region Forecast, 2022-2032
6.9 Tele-sampling
6.9.1 Global Tele-sampling Market Forecast, 2022-2032
6.9.2 Global Tele-sampling Market by Region Forecast, 2022-2032
6.10 Online Services
6.10.1 Global Online Services Market Forecast, 2022-2032
6.10.2 Global Online Services Market by Region Forecast, 2022-2032

7 Global Pharma Contract Sales Market Analysis by Co-Promotion
7.1 Key Findings
7.2 Commercial Aspects
7.3 Co-Promotion Segment Growth Prospects
7.4 Global Pharma Contract Sales Market Share by Co-Promotion, 2022 & 2032
7.5 Global Pharma Contract Sales Market by Co-Promotion
7.6 Marketing Research and Consulting
7.6.1 Global Marketing Research and Consulting Market Forecast, 2022-2032
7.6.2 Global Marketing Research and Consulting Market by Region Forecast, 2022-2032
7.7 Product Commercialization
7.7.1 Global Product Commercialization Market Forecast, 2022-2032
7.7.2 Global Product Commercialization Market by Region Forecast, 2022-2032
7.8 Territory Optimization & Alignment
7.8.1 Global Territory Optimization & Alignment Market Forecast, 2022-2032
7.8.2 Global Territory Optimization & Alignment Market by Region Forecast, 2022-2032
7.9 Brand Management
7.9.1 Global Brand Management Market Forecast, 2022-2032
7.9.2 Global Brand Management Market by Region Forecast, 2022-2032
7.10 Mature Product Line Support
7.10.1 Global Mature Product Line Support Market Forecast, 2022-2032
7.10.2 Global Mature Product Line Support Market by Region Forecast, 2022-2032
7.11 Rest All CSO Services
7.11.1 Global Rest All CSO Services Market Forecast, 2022-2032
7.11.2 Global Rest All CSO Services Market by Region Forecast, 2022-2032

8 Global Pharma Contract Sales Market Analysis by Therapeutics
8.1 Key Findings
8.2 Commercial Aspects
8.3 Therapeutics Segment Growth Prospects
8.4 Global Pharma Contract Sales Market Share by Therapeutics, 2022 & 2032
8.5 Global Pharma Contract Sales Market by Therapeutics
8.6 Cardiovascular Disease
8.6.1 Global Cardiovascular Disease Market Forecast, 2022-2032
8.6.2 Global Cardiovascular Disease Market by Region Forecast, 2022-2032
8.7 Metabolic Disorders
8.7.1 Global Metabolic Disorders Market Forecast, 2022-2032
8.7.2 Global Metabolic Disorders Market by Region Forecast, 2022-2032
8.8 Oncology
8.8.1 Global Oncology Market Forecast, 2022-2032
8.8.2 Global Oncology Market by Region Forecast, 2022-2032
8.9 Alzheimer's Disease
8.9.1 Global Alzheimer's Disease Market Forecast, 2022-2032
8.9.2 Global Alzheimer's Disease Market by Region Forecast, 2022-2032
8.10 Diabetes
8.10.1 Global Diabetes Market Forecast, 2022-2032
8.10.2 Global Diabetes Market by Region Forecast, 2022-2032
8.11 Other Therapeutics
8.11.1 Global Other Therapeutics Market Forecast, 2022-2032
8.11.2 Global Other Therapeutics Market by Region Forecast, 2022-2032

9 Global Pharma Contract Sales Market Analysis, by Region
9.1 Key Findings
9.2 Global Market Outlook
9.3 Region Segment Growth Prospects
9.4 Global Pharma Contract Sales Market Share by Region, 2022 & 2032
9.5 Global Pharma Contract Sales Market Size Estimation and Forecast
9.5.1 Pre-COVID-19 Market Scenario
9.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
9.6 Global Pharma Contract Sales Market Size Estimation and Forecast, by Region
9.6.1 Pre-COVID-19 Market Scenario
9.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

10 North America Pharma Contract Sales Market Analysis
10.1 Key Findings
10.2 North America Pharma Contract Sales Market Attractiveness Index
10.3 North America Pharma Contract Sales Market Size Estimation and Forecast by Value
10.4 North America Pharma Contract Sales Market Size Estimation and Forecast by Country
10.5 North America Pharma Contract Sales Market Size Estimation and Forecast by Type
10.6 North America Pharma Contract Sales Market Size Estimation and Forecast by Personal Promotion
10.7 North America Pharma Contract Sales Market Size Estimation and Forecast by Non-Personal Promotion
10.8 North America Pharma Contract Sales Market Size Estimation and Forecast by Co-Promotion
10.9 North America Pharma Contract Sales Market Size Estimation and Forecast by Therapeutics
10.10 U.S.
10.10.1 U.S. Pharma Contract Sales Market by Value
10.11 Canada
10.11.1 Canada Pharma Contract Sales Market by Value

11 Europe Pharma Contract Sales Market Analysis
11.1 Key Findings
11.2 Europe Pharma Contract Sales Market Attractiveness Index
11.3 Europe Pharma Contract Sales Market Size Estimation and Forecast by Value
11.4 Europe Pharma Contract Sales Market Size Estimation and Forecast by Country
11.5 Europe Pharma Contract Sales Market Size Estimation and Forecast by Type
11.6 Europe Pharma Contract Sales Market Size Estimation and Forecast by Personal Promotion
11.7 Europe Pharma Contract Sales Market Size Estimation and Forecast by Non-Personal Promotion
11.8 Europe Pharma Contract Sales Market Size Estimation and Forecast by Co-Promotion
11.9 Europe Pharma Contract Sales Market Size Estimation and Forecast by Therapeutics
11.10 Germany
11.10.1 Germany Pharma Contract Sales Market by Value
11.11 UK
11.11.1 UK Pharma Contract Sales Market by Value
11.12 France
11.12.1 France Pharma Contract Sales Market by Value
11.13 Italy
11.13.1 Italy Pharma Contract Sales Market by Value
11.14 Spain
11.14.1 Spain Pharma Contract Sales Market by Value
11.15 Rest of Europe
11.15.1 Rest of Europe Pharma Contract Sales Market by Value

12 Asia-Pacific Pharma Contract Sales Market Analysis
12.1 Key Findings
12.2 Asia-Pacific Pharma Contract Sales Market Attractiveness Index
12.3 Asia-Pacific Pharma Contract Sales Market Size Estimation and Forecast by Value
12.4 Asia-Pacific Pharma Contract Sales Market Size Estimation and Forecast by Country
12.5 Asia-Pacific Pharma Contract Sales Market Size Estimation and Forecast by Type
12.6 Asia-Pacific Pharma Contract Sales Market Size Estimation and Forecast by Personal Promotion
12.7 Asia-Pacific Pharma Contract Sales Market Size Estimation and Forecast by Non-Personal Promotion
12.8 Asia-Pacific Pharma Contract Sales Market Size Estimation and Forecast by Co-Promotion
12.9 Asia-Pacific Pharma Contract Sales Market Size Estimation and Forecast by Therapeutics
12.10 China
12.10.1 China Pharma Contract Sales Market by Value
12.11 India
12.11.1 India Pharma Contract Sales Market by Value
12.12 Japan
12.12.1 Japan Pharma Contract Sales Market by Value
12.13 South Korea
12.13.1 South Korea Pharma Contract Sales Market by Value
12.14 Australia
12.14.1 Australia Pharma Contract Sales Market by Value
12.15 Rest of Asia-Pacific
12.15.1 Rest of Asia-Pacific Pharma Contract Sales Market by Value

13 Middle East & Africa Pharma Contract Sales Market Analysis
13.1 Key Findings
13.2 Middle East & Africa Pharma Contract Sales Market Attractiveness Index
13.3 Middle East & Africa Pharma Contract Sales Market Size Estimation and Forecast by Value
13.4 Middle East & Africa Pharma Contract Sales Market Size Estimation and Forecast by Country
13.5 Middle East & Africa Pharma Contract Sales Market Size Estimation and Forecast by Type
13.6 Middle East & Africa Pharma Contract Sales Market Size Estimation and Forecast by Personal Promotion
13.7 Middle East & Africa Pharma Contract Sales Market Size Estimation and Forecast by Non-Personal Promotion
13.8 Middle East & Africa Pharma Contract Sales Market Size Estimation and Forecast by Co-Promotion
13.9 Middle East & Africa Pharma Contract Sales Market Size Estimation and Forecast by Therapeutics
13.10 South Africa
13.10.1 South Africa Pharma Contract Sales Market by Value
13.11 Saudi Arabia
13.11.1 Saudi Arabia Pharma Contract Sales Market by Value
13.12 Turkey
13.12.1 Turkey Pharma Contract Sales Market by Value
13.13 Rest of MEA
13.13.1 Rest of MEA Pharma Contract Sales Market by Value

14 South America Pharma Contract Sales Market Analysis
14.1 Key Findings
14.2 South America Pharma Contract Sales Market Attractiveness Index
14.3 South America Pharma Contract Sales Market Size Estimation and Forecast by Value
14.4 South America Pharma Contract Sales Market Size Estimation and Forecast by Country
14.5 South America Pharma Contract Sales Market Size Estimation and Forecast by Type
14.6 South America Pharma Contract Sales Market Size Estimation and Forecast by Personal Promotion
14.7 South America Pharma Contract Sales Market Size Estimation and Forecast by Non-Personal Promotion
14.8 South America Pharma Contract Sales Market Size Estimation and Forecast by Co-Promotion
14.9 South America Pharma Contract Sales Market Size Estimation and Forecast by Therapeutics
14.10 Brazil
14.10.1 Brazil Pharma Contract Sales Market by Value
14.11 Mexico
14.11.1 Mexico Pharma Contract Sales Market by Value
14.12 Rest of South America
14.12.1 Rest of South America Pharma Contract Sales Market by Value

15 Competitive Landscape
15.1 Company Share Analysis
15.2 New Product/Service Launch as the Key Business Strategy in the Global Market
15.3 Acquisition as the Key Business Strategy in the Global Market
15.4 Partnership as the Key Business Strategy in the Global Market
15.5 Collaboration as the Key Business Strategy in the Global Market
15.6 Expansion as the Key Business Strategy in the Global Market
15.7 Agreement as the Key Business Strategy in the Global Market
15.8 Contract as the Key Business Strategy in the Global Market

16 Company Profiles
16.1 Apodi Healthcare Limited
16.1.1 Company Snapshot
16.1.2 Company Overview
16.1.3 Product Benchmarking
16.2 CMIC Holdings Co., Ltd
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Financial Analysis
16.2.4 Product Benchmarking
16.2.5 Strategic Outlook
16.3 Syneos Health Inc.
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Financial Analysis
16.3.4 Product Benchmarking
16.3.5 Strategic Outlook
16.4 IQVIA Holdings Inc.
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Financial Analysis
16.4.4 Product Benchmarking
16.4.5 Strategic Outlook
16.5 Marvecs GmbH
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Product Benchmarking
16.6 OnCall LLC
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Product Benchmarking
16.7 Publicis Groupe SA
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Financial Analysis
16.7.4 Product Benchmarking
16.7.5 Strategic Outlook
16.8 Sofip SA
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Product Benchmarking
16.9 UDG Healthcare PLC
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Financial Analysis
16.9.4 Product Benchmarking
16.9.5 Strategic Outlook
16.10 Amplity Health
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Product Benchmarking
16.10.4 Strategic Outlook
16.11 Granard Pharmaceuticals
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Product Benchmarking
16.12 Vanguard Pharma
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Product Benchmarking
16.13 GTS Solution
16.13.1 Company Snapshot
16.13.2 Company Overview
16.13.3 Product Benchmarking
16.14 MaBiCo (Contract Sales Organization)
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Product Benchmarking
16.15 Sales Partnerships Inc.
16.15.1 Company Snapshot
16.15.2 Company Overview
16.15.3 Product Benchmarking
16.16 QFR Solutions
16.16.1 Company Snapshot
16.16.2 Company Overview
16.16.3 Product Benchmarking

17 Conclusion and Recommendations
17.1 Concluding Remarks from Visiongain
17.2 Recommendations for Market Players

List of Tables
Table 1 Global Pharma Contract Sales Market Snapshot, 2022 & 2032 (US million, CAGR %)
Table 2 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 3 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 4 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 5 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 6 Global Pharma Contract Sales Market by Type, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 7 Global Personal Promotion Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 8 Global Personal Promotion Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 9 Global Non-Personal Promotion Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 10 Global Non-Personal Promotion Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 11 Global Co-Promotion Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 12 Global Co-Promotion Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 13 Global Pharma Contract Sales Market by Personal Promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 14 Global Standard Field Force Roles Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 15 Global Standard Field Force Roles Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 16 Global Sales Deployment Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 17 Global Sales Deployment Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 18 Global Vacancy Coverage Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 19 Global Vacancy Coverage Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 20 Global HCP Educational Programs Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 21 Global HCP Educational Programs Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 22 Global HCP Educational Programs Market by Region, 2022-2032 (US$ Million)
Table 23 Global Key Account Management Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 24 Global Key Account Management Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 25 Global Other Personal Promotion Services Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 26 Global Other Personal Promotion Services Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 27 Global Pharma Contract Sales Market by Non-Personal Promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 28 Global Contact Center Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 29 Global Contact Center Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 30 Global Tele-detailing Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 31 Global Tele-detailing Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 32 Global Medical Call Centers Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 33 Global Medical Call Centers Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 34 Global Tele-sampling Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 35 Global Tele-sampling Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 36 Global Online Services Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 37 Global Online Services Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 38 Global Pharma Contract Sales Market by Co-promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 39 Global Marketing Research and Consulting Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 40 Global Marketing Research and Consulting Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 41 Global Product Commercialization Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 42 Global Product Commercialization Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 43 Global Territory Optimization & Alignment Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 44 Global Territory Optimization & Alignment Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 45 Global Brand Management Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 46 Global Brand Management Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 47 Global Mature Product Line Support Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 48 Global Mature Product Line Support Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 49 Global Rest All CSO Services Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 50 Global Rest All CSO Services Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 51 Global Pharma Contract Sales Market by Therapeutics, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 52 Global Cardiovascular Disease Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 53 Global Cardiovascular Disease Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 54 Global Metabolic Disorders Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 55 Global Metabolic Disorders Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 56 Global Oncology Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 57 Global Oncology Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 58 Global Alzheimer's Disease Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 59 Global Alzheimer's Disease Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 60 Global Diabetes Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 61 Global Diabetes Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 62 Global Other Therapeutics Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 63 Global Other Therapeutics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 64 Global Pharma Contract Sales Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 65 Global Pharma Contract Sales Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 66 Global Pharma Contract Sales Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 67 Global Pharma Contract Sales Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 68 Global Pharma Contract Sales Market Forecast, 2022-2032 (US$ Million, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 69 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 70 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 71 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 72 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 73 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 74 North America Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 75 North America Pharma Contract Sales Market by Country, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 76 North America Pharma Contract Sales Market by Type, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 77 North America Pharma Contract Sales Market by Personal Promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 78 North America Pharma Contract Sales Market by Non-Personal Promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 79 North America Pharma Contract Sales Market by Co-promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 80 North America Pharma Contract Sales Market by Therapeutics, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 81 U.S. Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 82 Canada Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 83 Europe Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 84 Europe Pharma Contract Sales Market by Country, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 85 Europe Pharma Contract Sales Market by Type, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 86 Europe Pharma Contract Sales Market by Personal Promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 87 Europe Pharma Contract Sales Market by Non-Personal Promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 88 Europe Pharma Contract Sales Market by Co-promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 89 Europe Pharma Contract Sales Market by Therapeutics, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 90 Germany Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 91 UK Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 92 France Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 93 Italy Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 94 Spain Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 95 Rest of Europe Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 96 Asia-Pacific Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 97 Asia-Pacific Pharma Contract Sales Market by Country, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 98 Asia-Pacific Pharma Contract Sales Market by Type, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 99 Asia-Pacific Pharma Contract Sales Market by Personal Promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 100 Asia-Pacific Pharma Contract Sales Market by Non-Personal Promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 101 Asia-Pacific Pharma Contract Sales Market by Co-promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 102 Asia-Pacific Pharma Contract Sales Market by Therapeutics, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 103 China Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 104 India Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 105 Japan Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 106 South Korea Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 107 Australia Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 108 Rest of Asia-Pacific Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 109 Middle East & Africa Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 110 Middle East & Africa Pharma Contract Sales Market by Country, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 111 Middle East & Africa Pharma Contract Sales Market by Type, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 112 Middle East & Africa Pharma Contract Sales Market by Personal Promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 113 Middle East & Africa Pharma Contract Sales Market by Non-Personal Promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 114 Middle East & Africa Pharma Contract Sales Market by Co-promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 115 Middle East & Africa Pharma Contract Sales Market by Therapeutics, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 116 South Africa Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 117 Saudi Arabia Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 118 Turkey Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 119 Rest of Middle East & Africa Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 120 South America Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 121 South America Pharma Contract Sales Market by Country, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 122 South America Pharma Contract Sales Market by Type, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 123 South America Pharma Contract Sales Market by Personal Promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 124 South America Pharma Contract Sales Market by Non-Personal Promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 125 South America Pharma Contract Sales Market by Co-promotion, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 126 South America Pharma Contract Sales Market by Therapeutics, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 127 Brazil Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 128 Mexico Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 129 Rest of South America Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Table 130 New Product Launch Business Strategies Adopted by Key Players in Global Pharma Contract Sales Market
Table 131 Acquisition Business Strategies Adopted by Key Players in Global Pharma Contract Sales Market
Table 132 Partnership Strategy Adopted by Key Players in Global Pharma Contract Sales Market, 2018-2021
Table 133 Collaboration Business Strategies Adopted by Key Players in Global Pharma Contract Sales Market
Table 134 Expansion Business Strategies Adopted by Key Players in Global Pharma Contract Sales Market
Table 135 Agreement Business Strategies Adopted by Key Players in Global Pharma Contract Sales Market
Table 136 Contract Business Strategies Adopted by Key Players in Global Pharma Contract Sales Market
Table 137 Apodi Healthcare Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 138 Apodi Healthcare Limited: Product Benchmarking
Table 139 CMIC Holdings Co., Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 140 CMIC Holdings Co., Ltd: Product Benchmarking
Table 141 CMIC Holdings Co., Ltd: Strategic Outlook
Table 142 Syneos Health Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 143 Syneos Health Inc.: Product Benchmarking
Table 144 Syneos Health Inc.: Strategic Outlook
Table 145 IQVIA Holdings Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 146 IQVIA Holdings Inc.: Product Benchmarking
Table 147 IQVIA Holdings Inc.: Strategic Outlook
Table 148 Marvecs GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 149 Marvecs GmbH: Product Benchmarking
Table 150 OnCall LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 151 OnCall LLC: Product Benchmarking
Table 152 Publicis Groupe SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 153 Publicis Groupe SA: Product Benchmarking
Table 154 Publicis Groupe SA: Strategic Outlook
Table 155 Sofip SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 156 Sofip SA: Product Benchmarking
Table 157 UDG Healthcare PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 158 UDG Healthcare PLC: Product Benchmarking
Table 159 UDG Healthcare PLC: Strategic Outlook
Table 160 Amplity Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 161 Amplity Health: Product Benchmarking
Table 162 Amplity Health: Strategic Outlook
Table 163 Granard Pharmaceuticals: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 164 Granard Pharmaceuticals: Product Benchmarking
Table 165 Vanguard Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 166 Vanguard Pharma: Product Benchmarking
Table 167 GTS Solution: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 168 GTS Solution: Product Benchmarking
Table 169 MaBiCo (Contract Sales Organization): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 170 MaBiCo (Contract Sales Organization): Product Benchmarking
Table 171 Sales Partnerships Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 172 Sales Partnerships Inc.: Product Benchmarking
Table 173 QFR Solutions: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 174 QFR Solutions: Product Benchmarking

List of Figures
Figure 1 Global Pharma Contract Sales Market Segmentation
Figure 2 Global Pharma Contract Sales Market Forecast by Region: Market Attractiveness Index
Figure 3 Global Pharma Contract Sales Market by Type: Market Attractiveness Index
Figure 4 Global Pharma Contract Sales Market by Personal Promotion: Market Attractiveness Index
Figure 5 Global Pharma Contract Sales Market by Non-Personal Promotion: Market Attractiveness Index
Figure 6 Global Pharma Contract Sales Market by Co-promotion: Market Attractiveness Index
Figure 7 Global Pharma Contract Sales Market by Therapeutics: Market Attractiveness Index
Figure 8 Global Pharma Contract Sales Market: Market Dynamics
Figure 9 Global COVID Impact Analysis: Pharma Contract Sales Market Recovery Scenarios
Figure 10 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%)): “V” Shaped Recovery
Figure 11 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%)): “U” Shaped Recovery
Figure 12 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%)): “W” Shaped Recovery
Figure 13 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%)): “L” Shaped Recovery
Figure 14 Global Pharma Contract Sales Market: Porter’s Five Forces Analysis
Figure 15 Global Pharma Contract Sales Market Forecast by Type 2022, 2027, 2032 (Revenue, CAGR%)
Figure 16 Global Pharma Contract Sales Market Forecast by Type 2022, 2032 (Revenue, CAGR%)
Figure 17 Global Pharma Contract Sales Market by Type, 2022-2032 (US$ Million)
Figure 18 Global Personal Promotion Market Forecast, 2022-2032 (US$ Million)
Figure 19 Global Personal Promotion Market by Region, 2022-2032 (US$ Million)
Figure 20 Global Non-Personal Promotion Market Forecast, 2022-2032 (US$ Million)
Figure 21 Global Non-Personal Promotion Market by Region, 2022-2032 (US$ Million)
Figure 22 Global Co-Promotion Market Forecast, 2022-2032 (US$ Million)
Figure 23 Global Co-Promotion Market by Region, 2022-2032 (US$ Million)
Figure 24 Global Pharma Contract Sales Market Forecast by Personal Promotion 2022, 2027, 2032 (Revenue, CAGR%)
Figure 25 Global Pharma Contract Sales Market Forecast by Personal Promotion 2022, 2032 (Revenue, CAGR%)
Figure 26 Global Pharma Contract Sales Market by Personal Promotion, 2022-2032 (US$ Million)
Figure 27 Global Standard Field Force Roles Market Forecast, 2022-2032 (US$ Million)
Figure 28 Global Standard Field Force Roles Market by Region, 2022-2032 (US$ Million)
Figure 29 Global Sales Deployment Market Forecast, 2022-2032 (US$ Million)
Figure 30 Global Sales Deployment Market by Region, 2022-2032 (US$ Million)
Figure 31 Global Vacancy Coverage Market Forecast, 2022-2032 (US$ Million)
Figure 32 Global Vacancy Coverage Market by Region, 2022-2032 (US$ Million)
Figure 33 Global HCP Educational Programs Market Forecast, 2022-2032 (US$ Million)
Figure 34 Global HCP Educational Programs Market by Region, 2022-2032 (US$ Million)
Figure 35 Global Key Account Management Market Forecast, 2022-2032 (US$ Million)
Figure 36 Global Key Account Management Market by Region, 2022-2032 (US$ Million)
Figure 37 Global Other Personal Promotion Services Market Forecast, 2022-2032 (US$ Million)
Figure 38 Global Other Personal Promotion Services Market by Region, 2022-2032 (US$ Million)
Figure 39 Global Pharma Contract Sales Market Forecast by Non-Personal Promotion 2022, 2027, 2032 (Revenue, CAGR%)
Figure 40 Global Pharma Contract Sales Market Forecast by Non-Personal Promotion 2022, 2032 (Revenue, CAGR%)
Figure 41 Global Pharma Contract Sales Market by Non-Personal Promotion, 2022-2032 (US$ Million)
Figure 42 Global Contact Center Market Forecast, 2022-2032 (US$ Million)
Figure 43 Global Contact Center Market by Region, 2022-2032 (US$ Million)
Figure 44 Global Tele-detailing Market Forecast, 2022-2032 (US$ Million)
Figure 45 Global Tele-detailing Market by Region, 2022-2032 (US$ Million)
Figure 46 Global Medical Call Centers Market Forecast, 2022-2032 (US$ Million)
Figure 47 Global Medical Call Centers Market by Region, 2022-2032 (US$ Million)
Figure 48 Global Tele-sampling Market Forecast, 2022-2032 (US$ Million)
Figure 49 Global Tele-sampling Market by Region, 2022-2032 (US$ Million)
Figure 50 Global Online Services Market Forecast, 2022-2032 (US$ Million)
Figure 51 Global Online Services Market by Region, 2022-2032 (US$ Million)
Figure 52 Global Pharma Contract Sales Market Forecast by Co-Promotion 2022, 2027, 2032 (Revenue, CAGR%)
Figure 53 Global Pharma Contract Sales Market Forecast by Co-Promotion 2022, 2032 (Revenue, CAGR%)
Figure 54 Global Pharma Contract Sales Market by Co-Promotion, 2022-2032 (US$ Million)
Figure 55 Global Marketing Research and Consulting Market Forecast, 2022-2032 (US$ Million)
Figure 56 Global Marketing Research and Consulting Market by Region, 2022-2032 (US$ Million)
Figure 57 Global Product Commercialization Market Forecast, 2022-2032 (US$ Million)
Figure 58 Global Product Commercialization Market by Region, 2022-2032 (US$ Million)
Figure 59 Global Territory Optimization & Alignment Market Forecast, 2022-2032 (US$ Million)
Figure 60 Global Territory Optimization & Alignment Market by Region, 2022-2032 (US$ Million)
Figure 61 Global Brand Management Market Forecast, 2022-2032 (US$ Million)
Figure 62 Global Brand Management Market by Region, 2022-2032 (US$ Million)
Figure 63 Global Mature Product Line Support Market Forecast, 2022-2032 (US$ Million, AGR (%))
Figure 64 Global Mature Product Line Support Market by Region, 2022-2032 (US$ Million)
Figure 65 Global Rest All CSO Services Market Forecast, 2022-2032 (US$ Million, AGR (%))
Figure 66 Global Rest All CSO Services Market by Region, 2022-2032 (US$ Million)
Figure 67 Global Pharma Contract Sales Market Forecast by Therapeutics 2022, 2027, 2032 (Revenue, CAGR%)
Figure 68 Global Pharma Contract Sales Market Forecast by Therapeutics 2022, 2032 (Revenue, CAGR (%))
Figure 69 Global Pharma Contract Sales Market by Therapeutics, 2022-2032 (US$ Million)
Figure 70 Global Cardiovascular Disease Market Forecast, 2022-2032 (US$ Million)
Figure 71 Global Cardiovascular Disease Market by Region, 2022-2032 (US$ Million)
Figure 72 Global Metabolic Disorders Market Forecast, 2022-2032 (US$ Million)
Figure 73 Global Metabolic Disorders Market by Region, 2022-2032 (US$ Million)
Figure 74 Global Oncology Market Forecast, 2022-2032 (US$ Million)
Figure 75 Global Oncology Market by Region, 2022-2032 (US$ Million)
Figure 76 Global Alzheimer's Disease Market Forecast, 2022-2032 (US$ Million)
Figure 77 Global Alzheimer's Disease Market by Region, 2022-2032 (US$ Million)
Figure 78 Global Diabetes Market Forecast, 2022-2032 (US$ Million)
Figure 79 Global Diabetes Market by Region, 2022-2032 (US$ Million)
Figure 80 Global Other Therapeutics Market Forecast, 2022-2032 (US$ Million)
Figure 81 Global Other Therapeutics Market by Region, 2022-2032 (US$ Million)
Figure 82 Global Pharma Contract Sales Market Forecast by Region 2022, 2027, 2032 (Revenue, CAGR%)
Figure 83 Global Pharma Contract Sales Market Forecast by Region 2022, 2032 (Revenue, CAGR%)
Figure 84 Global Pharma Contract Sales Market Forecast, 2022-2032 (US$ Million, AGR (%))
Figure 85 Global Pharma Contract Sales Market Forecast, 2021-2031 (US$ Million, AGR (%)) (V-Shape Recovery)
Figure 86 Global Pharma Contract Sales Market Forecast, 2021-2031 (US$ Million, AGR (%)) (W-Shape Recovery)
Figure 87 Global Pharma Contract Sales Market Forecast, 2021-2031 (US$ Million, AGR (%)) (U-Shape Recovery)
Figure 88 Global Pharma Contract Sales Market Forecast, 2021-2031 (US$ Million, AGR (%)) (L-Shape Recovery)
Figure 89 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%))
Figure 90 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%)) (V-Shaped Recovery Scenario)
Figure 91 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%)) (W-Shaped Recovery Scenario)
Figure 92 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%)) (U-Shaped Recovery Scenario)
Figure 93 Global Pharma Contract Sales Market by Region, 2022-2032 (US$ Million, AGR (%)) (L-Shaped Recovery Scenario)
Figure 94 North America Pharma Contract Sales Market Attractiveness Index
Figure 95 North America Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%))
Figure 96 North America Pharma Contract Sales Market Forecast by Country, 2022-2032 (US$ Million, AGR %)
Figure 97 North America Pharma Contract Sales Market Share Forecast by Country, 2022 & 2032 (%)
Figure 98 North America Pharma Contract Sales Market Forecast by Type, 2022-2032 (US$ Million, AGR %)
Figure 99 North America Pharma Contract Sales Market Share Forecast by Type, 2022 & 2032 (%)
Figure 100 North America Pharma Contract Sales Market Forecast by Personal Promotion, 2022-2032 (US$ Million, AGR %)
Figure 101 North America Pharma Contract Sales Market Share Forecast by Personal Promotion, 2022 & 2032 (%)
Figure 102 North America Pharma Contract Sales Market Forecast by Non-Personal Promotion, 2022-2032 (US$ Million, AGR %)
Figure 103 North America Pharma Contract Sales Market Share Forecast by Non-Personal Promotion, 2022 & 2032 (%)
Figure 104 North America Pharma Contract Sales Market Forecast by Co-Promotion, 2022-2032 (US$ Million, AGR %)
Figure 105 North America Pharma Contract Sales Market Share Forecast by Co-Promotion, 2022 & 2032 (%)
Figure 106 North America Pharma Contract Sales Market Forecast by Therapeutics, 2022-2032 (US$ Million, AGR %)
Figure 107 North America Pharma Contract Sales Market Share Forecast by Therapeutics, 2022 & 2032 (%)
Figure 108 U.S. Pharma Contract Sales Market Forecast, 2022-2032 (US$ Million, AGR %)
Figure 109 Canada Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 110 Europe Pharma Contract Sales Market Attractiveness Index
Figure 111 Europe Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%))
Figure 112 Europe Pharma Contract Sales Market Forecast by Country, 2022-2032 (US$ Million, AGR %)
Figure 113 Europe Pharma Contract Sales Market Share Forecast by Country, 2022 & 2032 (%)
Figure 114 Europe Pharma Contract Sales Market Forecast by Type, 2022-2032 (US$ Million, AGR %)
Figure 115 Europe Pharma Contract Sales Market Share Forecast by Type, 2022 & 2032 (%)
Figure 116 Europe Pharma Contract Sales Market Forecast by Personal Promotion, 2022-2032 (US$ Million, AGR %)
Figure 117 Europe Pharma Contract Sales Market Share Forecast by Personal Promotion, 2022 & 2032 (%)
Figure 118 Europe Pharma Contract Sales Market Forecast by Non-Personal Promotion, 2022-2032 (US$ Million, AGR %)
Figure 119 Europe Pharma Contract Sales Market Share Forecast by Non-Personal Promotion, 2022 & 2032 (%)
Figure 120 Europe Pharma Contract Sales Market Forecast by Co-Promotion, 2022-2032 (US$ Million, AGR %)
Figure 121 Europe Pharma Contract Sales Market Share Forecast by Co-Promotion, 2022 & 2032 (%)
Figure 122 North America Pharma Contract Sales Market Forecast by Therapeutics, 2022-2032 (US$ Million, AGR %)
Figure 123 Europe Pharma Contract Sales Market Share Forecast by Therapeutics, 2022 & 2032 (%)
Figure 124 Germany Pharma Contract Sales Market Forecast, 2022-2032 (US$ Million, AGR %)
Figure 125 UK Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 126 France Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 127 Italy Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 128 Spain Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 129 Rest of Europe Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 130 Asia-Pacific Pharma Contract Sales Market Attractiveness Index
Figure 131 Asia-Pacific Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%))
Figure 132 Asia-Pacific Pharma Contract Sales Market Forecast by Country, 2022-2032 (US$ Million, AGR %)
Figure 133 Asia-Pacific Pharma Contract Sales Market Share Forecast by Country, 2022 & 2032 (%)
Figure 134 Asia-Pacific Pharma Contract Sales Market Forecast by Type, 2022-2032 (US$ Million, AGR %)
Figure 135 Asia-Pacific Pharma Contract Sales Market Share Forecast by Type, 2022 & 2032 (%)
Figure 136 Asia-Pacific Pharma Contract Sales Market Forecast by Personal Promotion, 2022-2032 (US$ Million, AGR %)
Figure 137 Asia-Pacific Pharma Contract Sales Market Share Forecast by Personal Promotion, 2022 & 2032 (%)
Figure 138 Asia-Pacific Pharma Contract Sales Market Forecast by Non-Personal Promotion, 2022-2032 (US$ Million, AGR %)
Figure 139 Asia-Pacific Pharma Contract Sales Market Share Forecast by Non-Personal Promotion, 2022 & 2032 (%)
Figure 140 Asia-Pacific Pharma Contract Sales Market Forecast by Co-Promotion, 2022-2032 (US$ Million, AGR %)
Figure 141 Asia-Pacific Pharma Contract Sales Market Share Forecast by Co-Promotion, 2022 & 2032 (%)
Figure 142 Asia-Pacific Pharma Contract Sales Market Forecast by Therapeutics, 2022-2032 (US$ Million, AGR %)
Figure 143 Asia-Pacific Pharma Contract Sales Market Share Forecast by Therapeutics, 2022 & 2032 (%)
Figure 144 China Pharma Contract Sales Market Forecast, 2022-2032 (US$ Million, AGR %)
Figure 145 India Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 146 Japan Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 147 South Korea Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 148 Australia Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 149 Rest of Asia-Pacific Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 150 Middle East & Africa Pharma Contract Sales Market Attractiveness Index
Figure 151 Middle East & Africa Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%))
Figure 152 Middle East & Africa Pharma Contract Sales Market Forecast by Country, 2022-2032 (US$ Million, AGR %)
Figure 153 Middle East & Africa Pharma Contract Sales Market Share Forecast by Country, 2022 & 2032 (%)
Figure 154 Middle East & Africa Pharma Contract Sales Market Forecast by Type, 2022-2032 (US$ Million, AGR %)
Figure 155 Middle East & Africa Pharma Contract Sales Market Share Forecast by Type, 2022 & 2032 (%)
Figure 156 Middle East & Africa Pharma Contract Sales Market Forecast by Personal Promotion, 2022-2032 (US$ Million, AGR %)
Figure 157 Middle East & Africa Pharma Contract Sales Market Share Forecast by Personal Promotion, 2022 & 2032 (%)
Figure 158 Middle East & Africa Pharma Contract Sales Market Forecast by Non-Personal Promotion, 2022-2032 (US$ Million, AGR %)
Figure 159 Middle East & Africa Pharma Contract Sales Market Share Forecast by Non-Personal Promotion, 2022 & 2032 (%)
Figure 160 Middle East & Africa Pharma Contract Sales Market Forecast by Co-Promotion, 2022-2032 (US$ Million, AGR %)
Figure 161 Middle East & Africa Pharma Contract Sales Market Share Forecast by Co-Promotion, 2022 & 2032 (%)
Figure 162 Middle East & Africa Pharma Contract Sales Market Forecast by Therapeutics, 2022-2032 (US$ Million, AGR %)
Figure 163 Middle East & Africa Pharma Contract Sales Market Share Forecast by Therapeutics, 2022 & 2032 (%)
Figure 164 South Africa Pharma Contract Sales Market Forecast, 2022-2032 (US$ Million, AGR %)
Figure 165 Saudi Arabia Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 166 Turkey Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 167 Saudi Arabia Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 168 South America Pharma Contract Sales Market Attractiveness Index
Figure 169 South America Pharma Contract Sales Market by Value, 2022-2032 (US$ Million, AGR (%))
Figure 170 South America Pharma Contract Sales Market Forecast by Country, 2022-2032 (US$ Million, AGR %)
Figure 171 South America Pharma Contract Sales Market Share Forecast by Country, 2022 & 2032 (%)
Figure 172 South America Pharma Contract Sales Market Forecast by Type, 2022-2032 (US$ Million, AGR %)
Figure 173 South America Pharma Contract Sales Market Share Forecast by Type, 2022 & 2032 (%)
Figure 174 South America Pharma Contract Sales Market Forecast by Personal Promotion, 2022-2032 (US$ Million, AGR %)
Figure 175 South America Pharma Contract Sales Market Share Forecast by Personal Promotion, 2022 & 2032 (%)
Figure 176 South America Pharma Contract Sales Market Forecast by Non-Personal Promotion, 2022-2032 (US$ Million, AGR %)
Figure 177 South America Pharma Contract Sales Market Share Forecast by Non-Personal Promotion, 2022 & 2032 (%)
Figure 178 South America Pharma Contract Sales Market Forecast by Co-Promotion, 2022-2032 (US$ Million, AGR %)
Figure 179 South America Pharma Contract Sales Market Share Forecast by Co-Promotion, 2022 & 2032 (%)
Figure 180 South America Pharma Contract Sales Market Forecast by Therapeutics, 2022-2032 (US$ Million, AGR %)
Figure 181 South America Pharma Contract Sales Market Share Forecast by Therapeutics, 2022 & 2032 (%)
Figure 182 Brazil Pharma Contract Sales Market Forecast, 2022-2032 (US$ Million, AGR %)
Figure 183 Mexico Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 184 Rest of South America Pharma Contract Sales Market Forecast by Value, 2022-2032 (US$ Million, AGR %)
Figure 185 Global Pharma Contract Sales Market: Company Share Analysis, 2021
Figure 186 CMIC Holdings Co., Ltd: Net Revenue, 2017-2021 (US$ Million, AGR%)
Figure 187 CMIC Holdings Co., Ltd: Gross Profit, 2017-2021 (US$ Million, AGR%)
Figure 188 CMIC Holdings Co., Ltd: R&D, 2017-2021 (US$ Million, AGR%)
Figure 189 CMIC Holdings Co., Ltd: EBITDA, 2017-2021 (US$ Million, AGR%)
Figure 190 Syneos Health Inc.: Net Revenue, 2017-2021 (US$ Million, AGR%)
Figure 191 Syneos Health Inc.: Gross Profit, 2017-2021 (US$ Million, AGR%)
Figure 192 Syneos Health Inc.: EBITDA, 2017-2021 (US$ Million, AGR%)
Figure 193 IQVIA Holdings Inc.: Net Revenue, 2017-2021 (US$ Million, AGR%)
Figure 194 IQVIA Holdings Inc.: Gross Profit, 2017-2021 (US$ Million, AGR%)
Figure 195 IQVIA Holdings Inc.: EBITDA, 2017-2021 (US$ Million, AGR%)
Figure 196 Publicis Groupe SA: Net Revenue, 2017-2021 (US$ Million, AGR%)
Figure 197 Publicis Groupe SA: Gross Profit, 2017-2021 (US$ Million, AGR%)
Figure 198 Publicis Groupe SA: EBITDA, 2017-2021 (US$ Million, AGR%)
Figure 199 UDG Healthcare PLC: Net Revenue, 2017-2021 (US$ Million, AGR%)
Figure 200 UDG Healthcare PLC: Gross Profit, 2017-2021 (US$ Million, AGR%)
Figure 201 UDG Healthcare PLC: R&D, 2017-2021 (US$ Million, AGR%)
Figure 202 UDG Healthcare PLC: EBITDA, 2017-2021 (US$ Million, AGR%)

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

本レポートと同分野の最新刊レポートはありません。

Visiongain 社の最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

Visiongain社はどのような調査会社ですか?

英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。